preeclampsia: Preeclampsia is a hypertensive disorder of pregnancy that is characterized by new-onset hypertension with proteinuria presenting after 20 weeks of gestation, and depending on mild or severe forms may initially present with severe headache, visual disturbances, and hyperreflexia.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleonly females |
293373 |
2. Check conditionsNone |
293373 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
12340 |
4. Check minimum number of eventsNone |
12340 |
5. Include endpointsNone |
12340 |
6. Filter based on genotype QC (FinnGen only) |
12340 |
Control definitions (FinnGen only)
- Control exclude
- O15_OEDEM_PROTUR_HYPERT
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF5
- Parent code in ICD-10
- O10-O16
- Name in latin
- Hypertensio gestationalis sine proteinuria significanti
Similar endpoints
↥List of similar endpoints to
Gestational [pregnancy-induced] hypertension
based on the number of shared cases.
Similar with more cases:
- Pregnancy hypertension
- Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium
- Delivery, wide proxy
- Pregnancy, childbirth and the puerperium
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 88050 | 88050 | - |
| Only index persons | 86216 | 86216 | - |
| Unadjusted period prevalence (%) | |||
| Whole population | 2.52 | 2.52 | - |
| Only index persons | 3.17 | 3.17 | - |
| Median age at first event (years) | |||
| Whole population | - | 29.58 | - |
| Only index persons | - | 29.54 | - |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 12340 | 12340 | - |
| Unadjusted period prevalence (%) | 4.21 | 4.21 | - |
| Median age at first event (years) | 29.74 | 29.74 | - |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 11046
- Matched controls
- 110149
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
MA2AE
NOMESCO Finland
Ultrasound examination of pregnancy (at 12. week of gestaion or later) including basic examination of fetus
2.5
323.0
3812
19266
205
Kela drug reimbursment
Chronic hypertension
3.5
323.0
1995
6538
O13
ICD-10 Finland
Gestational [pregnancy-induced] hypertension
8132.5
323.0
7568
23
6423A
ICD-9 Finland
Hypertension complicating pregnancy, childbirth and the puerperium, Transient hypertension of pregnancy[HYPERTENSIO GRAVIDARUM, ENNEN SYNNYTYSTÄ]
+∞
323.0
1327
*
O10.0
ICD-10 Finland
Pre-existing essential hypertension complicating pregnancy, childbirth and the puerperium
5609.1
323.0
1043
*
I10
ICD-10 Finland
Essential (primary) hypertension
2.5
323.0
4562
23847
MA2DE
NOMESCO Finland
Detailed ultrasound examination of fetus including color doppler method
3.0
323.0
2398
9291
C07AG01
ATC
labetalol; systemic
60.0
323.0
784
140
MCA10
NOMESCO Finland
Lower uterine segment caesarean section
2.7
323.0
2708
11755
O14.0
ICD-10 Finland
Mild to moderate pre-eclampsia
+∞
323.0
1181
*
O14.9
ICD-10 Finland
Pre-eclampsia, unspecified
754.4
323.0
841
12
O14.1
ICD-10 Finland
Severe pre-eclampsia
4772.2
323.0
469
*
O24.4
ICD-10 Finland
Diabetes mellitus arising in pregnancy
3.1
323.0
2396
9116
63701
ICD-8 Finland
Pre-eclampsia, eclampsia and toxaemia, unspecified, Hypertonia
+∞
323.0
2223
*
63703
ICD-8 Finland
Pre-eclampsia, eclampsia and toxaemia, unspecified, Prae-eclampsia levis
+∞
272.7
261
*
Z35.8
ICD-10 Finland
Supervision of other high-risk pregnancies
2.6
263.9
2261
9851
MA2HE
NOMESCO Finland
Detailed morfological ultrasound examination of fetus
2.2
256.2
3651
20477
O82.10
ICD-10 Finland
Delivery by emergency caesarean section
3.1
250.1
1584
5690
Z36.3
ICD-10 Finland
Antenatal screening for malformations using ultrasound and other physical methods
2.0
242.7
4973
32184
6424A
ICD-9 Finland
Hypertension complicating pregnancy, childbirth and the puerperium, Mild or unspecified pre-eclampsia[PRAE-ECLAMPSIA LEVIS, ENNEN SYNNYTYSTÄ]
+∞
236.0
226
*
C09AA02
ATC
enalapril; systemic
2.9
205.0
1411
5307
O16
ICD-10 Finland
Unspecified maternal hypertension
96.4
196.7
218
23
C08CA01
ATC
amlodipine; oral
2.2
193.7
2358
12047
O80.8
ICD-10 Finland
Other single spontaneous delivery
3.0
189.4
1189
4194
Z39.2
ICD-10 Finland
Routine postpartum follow-up
2.0
186.8
2913
16508
O12.1
ICD-10 Finland
Gestational proteinuria
242.2
185.9
191
8
O34.2
ICD-10 Finland
Maternal care due to uterine scar from previous surgery
2.6
179.1
1448
5971
E66.01
ICD-10 Finland
Obesity due to excess calories
2.6
174.3
1393
5702
O36.5
ICD-10 Finland
Maternal care for poor fetal growth
3.8
172.6
796
2213
XMA22
NOMESCO Finland
General examination of pregnant woman
2.4
156.9
1449
6397
6420X
ICD-9 Finland
Hypertension complicating pregnancy, childbirth and the puerperium, Benign essential hypertension complicating pregnancy, childbirth and the puerperium
+∞
154.3
148
*
O12.0
ICD-10 Finland
Gestational oedema
66.0
151.3
176
27
6423B
ICD-9 Finland
Hypertension complicating pregnancy, childbirth and the puerperium, Transient hypertension of pregnancy[HYPERTENSIO GRAVIDARUM, SYNNYTYKSEN AIKANA]
+∞
151.2
145
*
SPAT1379
SPAT
Health check-up of pregnant person
2.0
145.1
2375
13494
MAC10
NOMESCO Finland
Antepartum dilatation of cervical canal
3.8
138.8
636
1751
ZXD05
NOMESCO Finland
Urgent procedure
1.7
136.8
3755
25296
W84
ICPC
Pregnancy high risk
2.9
131.7
856
3059
O47.0
ICD-10 Finland
False labour before 37 completed weeks of gestation
2.0
129.6
1889
10203
C08CA05
ATC
nifedipine; systemic
3.4
124.7
640
1930
C07AB02
ATC
metoprolol; systemic
2.2
122.7
1458
7209
A10BA02
ATC
metformin; oral
2.0
122.2
1858
10177
C07AB07
ATC
bisoprolol; oral
1.7
119.1
3267
21787
MAC96
NOMESCO Finland
Other induction or advancement of labour
3.1
116.4
682
2266
O80.0
ICD-10 Finland
Spontaneous vertex delivery
1.6
110.2
4982
37742
SPAT1197
SPAT
Extensive health check-up of expecting family
1.7
109.1
2611
16628
W78
ICPC
Pregnancy
1.7
108.4
2884
18955
O24.0
ICD-10 Finland
Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent
4.1
106.1
434
1077
MA2XE
NOMESCO Finland
Other obstetric ultrasound examination
2.0
105.8
1445
7544
O10.9
ICD-10 Finland
Unspecified pre-existing hypertension complicating pregnancy, childbirth and the puerperium
+∞
104.2
100
*
Z34.8
ICD-10 Finland
Supervision of other normal pregnancy
1.7
104.2
2902
19284
Z32.1
ICD-10 Finland
Pregnancy confirmed
1.8
103.8
1997
11832
SPAT1380
SPAT
Postpartum check-up
1.8
103.2
1947
11456
C09BA02
ATC
enalapril and diuretics; systemic
3.5
102.3
513
1515
O11
ICD-10 Finland
Pre-eclampsia superimposed on chronic hypertension
+∞
99.0
95
*
C09CA06
ATC
candesartan; oral
1.8
97.7
2024
12258
40199
ICD-8 Finland
Essential benign hypertension
12.7
96.0
175
139
C09CA01
ATC
losartan; oral
1.9
94.8
1597
9003
63702
ICD-8 Finland
Pre-eclampsia, eclampsia and toxaemia, unspecified, Oedema
+∞
93.8
90
*
Z35.9
ICD-10 Finland
Supervision of high-risk pregnancy, unspecified
2.5
89.6
735
3000
K85
ICPC
Elevated blood pressure
2.1
86.8
1075
5358
103
Kela drug reimbursment
Diabetes, insulin-treated
1.8
86.2
1571
9078
SPAT1317
SPAT
Planned health check-up monitoring, health check-up performed based on individual need
1.8
85.5
1771
10672
63704
ICD-8 Finland
Pre-eclampsia, eclampsia and toxaemia, unspecified, Prae-eclampsia gravis
+∞
85.4
82
*
63700
ICD-8 Finland
Pre-eclampsia, eclampsia and toxaemia, unspecified, Albuminuria (proteinuria)
+∞
85.4
82
*
O36.6
ICD-10 Finland
Maternal care for excessive fetal growth
2.4
84.1
761
3273
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
2.5
83.0
703
2917
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.8
82.7
1537
8927
Z34.9
ICD-10 Finland
Supervision of normal pregnancy, unspecified
1.7
81.3
2113
13606
MAC40
NOMESCO Finland
Pharmacological induction or advancement of labor
3.3
79.5
432
1355
SPAT1262
SPAT
Handing over of treatment supplies
1.9
77.4
1313
7374
W85
ICPC
Gestational diabetes
2.2
77.1
814
3769
MA1AE
NOMESCO Finland
Ultrasound examination of early pregnancy (before 12. postmenstrual week)
1.7
76.6
1968
12608
C08CA13
ATC
lercanidipine; oral
2.2
76.1
798
3686
C09DA01
ATC
losartan and diuretics; oral
2.4
74.9
698
3042
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.9
74.7
1203
6629
Z36.0
ICD-10 Finland
Antenatal screening for chromosomal anomalies
2.0
74.3
1013
5239
O68.0
ICD-10 Finland
Labour and delivery complicated by fetal heart rate anomaly
2.0
73.5
994
5121
O99.2
ICD-10 Finland
Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium
3.2
71.2
393
1247
SPAT1357
SPAT
Monitoring of problem during pregnancy
2.4
68.4
613
2614
O61.0
ICD-10 Finland
Failed medical induction of labour
4.1
67.9
280
700
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.9
66.7
1101
6105
O60
ICD-10 Finland
Preterm labour and delivery
2.5
66.7
542
2195
6424B
ICD-9 Finland
Hypertension complicating pregnancy, childbirth and the puerperium, Mild or unspecified pre-eclampsia[PRAE-ECLAMPSIA LEVIS, SYNNYTYKSEN AIKANA]
+∞
66.6
64
*
O24.9
ICD-10 Finland
Diabetes mellitus in pregnancy, unspecified
3.0
66.1
404
1374
6425A
ICD-9 Finland
Hypertension complicating pregnancy, childbirth and the puerperium, Severe pre-eclampsia[PRAE-ECLAMPSIA GRAVIS, ENNEN SYNNYTYSTÄ]
+∞
64.6
62
*
T90
ICPC
Diabetes non-insulin dependent
1.8
64.3
1290
7637
E66.9
ICD-10 Finland
Obesity, unspecified
2.6
63.1
476
1848
C03AA03
ATC
hydrochlorothiazide; oral
2.3
61.8
585
2566
O41.0
ICD-10 Finland
Oligohydramnios
2.8
61.4
422
1550
O82.0
ICD-10 Finland
Delivery by elective caesarean section
2.0
59.3
857
4517
C08CA02
ATC
felodipine; oral
2.5
59.2
475
1910
E66.8
ICD-10 Finland
Other obesity
2.1
58.3
721
3570
Z35.2
ICD-10 Finland
Supervision of pregnancy with other poor reproductive or obstetric history
2.7
58.3
426
1622
C09AA05
ATC
ramipril; oral
1.8
56.6
1142
6753
B01AB05
ATC
enoxaparin; parenteral
1.5
55.5
2473
17930
SPAT1196
SPAT
Monitoring of normal pregnancy
1.7
54.9
1360
8544
O99.80
ICD-10 Finland
The fear of childbirth
1.8
53.7
939
5292
WX307
NOMESCO Finland
Obstetric epidural analgesia
1.6
52.9
1493
9709
W92
ICPC
Compl labour/ delivery livebirth
2.5
52.6
421
1690
C09DA06
ATC
candesartan and diuretics; oral
2.3
51.9
486
2118
K86
ICPC
Hypertension uncomplicated
2.0
50.6
647
3245
O26.82
ICD-10 Finland
Exhaustion and fatigue pregnancy-related
2.5
49.7
399
1603
MAA00
NOMESCO Finland
Amniocentesis
2.4
48.8
442
1891
C02EA02
ATC
NA
4.4
47.7
178
406
O99.3
ICD-10 Finland
Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium
2.5
47.4
378
1513
Z87.5
ICD-10 Finland
Personal history of complications of pregnancy, childbirth and the puerperium
3.6
47.4
222
622
WX320
NOMESCO Finland
Spinalanesthesy
1.5
46.0
1965
14038
MAC01
NOMESCO Finland
Rupture of aminiotic membrane for induction of labor
2.5
45.6
364
1459
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
2.1
45.1
527
2544
6425B
ICD-9 Finland
Hypertension complicating pregnancy, childbirth and the puerperium, Severe pre-eclampsia[PRAE-ECLAMPSIA GRAVIS, SYNNYTYKSEN AIKANA]
+∞
44.8
43
*
E66.00
ICD-10 Finland
Metabolic syndrome
2.3
44.7
438
1952
C02CB01
ATC
NA
35.7
44.3
57
16
J01DA01
ATC
[U] cefalexin; systemic
1.3
44.2
6574
57859
MA2JE
NOMESCO Finland
Ultrasound screening of fetal nuchal translucency
1.5
43.6
1545
10582
WX306
NOMESCO Finland
Lumbar epidural anesthesy
1.6
43.1
1119
7092
O10.1
ICD-10 Finland
Pre-existing hypertensive heart disease complicating pregnancy, childbirth and the puerperium
+∞
42.7
41
*
SPAT1249
SPAT
Treatment-related counselling outside office
1.3
42.4
4121
33966
C02AC05
ATC
moxonidine; oral
3.2
42.4
235
750
C09CA03
ATC
valsartan; oral
2.1
42.3
491
2362
J01DB01
ATC
cefalexin; oral
1.4
41.7
8697
80223
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
1.6
40.6
1253
8295
A10AE04
ATC
insulin glargine; parenteral
2.0
40.2
567
2952
Y6099
ICD-8 Finland
Prenatal care and observation
2.2
39.4
441
2086
N02BE01
ATC
paracetamol; systemic, rectal
1.4
38.9
8866
82288
C07AG02
ATC
carvedilol; oral
2.6
38.5
287
1105
O30.0
ICD-10 Finland
Twin pregnancy
2.5
38.5
322
1324
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.5
38.1
1519
10650
Z34.0
ICD-10 Finland
Supervision of normal first pregnancy
1.4
38.0
2218
16749
O12.2
ICD-10 Finland
Gestational oedema with proteinuria
377.7
38.0
38
*
C10AA01
ATC
simvastatin; oral
1.4
37.9
1833
13368
C03CA01
ATC
furosemide; systemic
1.6
37.6
1152
7602
O99.89
ICD-10 Finland
Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium
2.3
37.5
373
1675
O24.1
ICD-10 Finland
Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, non-insulin-dependent
4.5
36.7
134
301
SPAT1399
SPAT
Acceptance of acknowledgement of paternity of child born outside of marriage before the birth of the child at the maternity clinic. Paternity Act, Section 16.
1.8
36.1
685
3951
O02.1
ICD-10 Finland
Missed abortion
1.6
36.0
933
5900
JDF11
NOMESCO Finland
Laparoscopic gastric bypass
2.7
35.9
252
938
O63.0
ICD-10 Finland
Prolonged first stage (of labour)
2.1
35.9
402
1905
A12BA01
ATC
potassium chloride; oral
3.2
35.9
193
604
SPAT1263
SPAT
Sampling
1.3
35.8
4180
35105
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
2.3
35.0
340
1509
W81
ICPC
Toxaemia of pregnancy
36.7
34.5
44
12
C07BB07
ATC
bisoprolol and thiazides; systemic
2.6
34.4
255
982
66120
ICD-8 Finland
Occipital presentation
14.2
34.0
58
41
MAX99
NOMESCO Finland
Assistance to normal delivery
1.4
33.8
1662
12129
4019X
ICD-9 Finland
Essential hypertension, Unspecified
5.4
33.6
103
192
O20.9
ICD-10 Finland
Haemorrhage in early pregnancy, unspecified
1.9
33.5
505
2693
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.3
33.4
2705
21492
C09DA03
ATC
valsartan and diuretics; oral
2.5
33.3
266
1067
O32.1
ICD-10 Finland
Maternal care for breech presentation
1.7
33.3
744
4510
66180
ICD-8 Finland
Occipital presentation
2.9
32.6
208
733
8811
FHL
Cesarean section
1.8
32.5
638
3720
Z35.0
ICD-10 Finland
Supervision of pregnancy with history of infertility
1.9
32.4
502
2707
A10BH01
ATC
sitagliptin; oral
2.0
32.2
448
2321
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
2.3
32.0
309
1370
G56.0
ICD-10 Finland
Carpal tunnel syndrome
1.5
31.7
1248
8704
O81.4
ICD-10 Finland
Vacuum extractor delivery
1.5
31.1
1001
6671
E11
ICD-10 Finland
Type 2 diabetes mellitus
1.7
30.8
744
4607
C07AB03
ATC
atenolol; systemic
2.3
30.7
289
1264
O26.88
ICD-10 Finland
Other specified pregnancy-related conditions
2.4
30.6
268
1130
O28.8
ICD-10 Finland
Other abnormal findings on antenatal screening of mother
2.8
30.1
202
734
MAE00
NOMESCO Finland
Outlet vacuum delivery
1.6
29.9
858
5559
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
1.5
29.9
1128
7789
A10AE05
ATC
insulin detemir; parenteral
2.0
29.6
380
1906
W29
ICPC
Pregnancy symptom/complaint other
1.9
29.5
441
2346
C07AB08
ATC
celiprolol; oral
3.8
29.2
128
342
6462A
ICD-9 Finland
Other complications of pregnancy, not elsewhere classified, Unspecified renal disease in pregnancy, without mention of hypertension
+∞
29.1
28
*
C09AA03
ATC
lisinopril; oral
2.5
28.9
235
955
Z36.4
ICD-10 Finland
Antenatal screening for fetal growth retardation using ultrasound and other physical methods
2.2
27.9
280
1262
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
2.0
27.6
350
1749
O68.8
ICD-10 Finland
Labour and delivery complicated by other evidence of fetal stress
2.8
27.3
183
664
ZXE00
NOMESCO Finland
One hour or less
1.3
27.1
3933
33588
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
1.5
27.1
1051
7295
63799
ICD-8 Finland
Pre-eclampsia, eclampsia and toxaemia, unspecified, Toxaemia, unspecified
+∞
27.1
26
*
E66
ICD-10 Finland
Obesity
1.8
27.0
472
2650
MA5AE
NOMESCO Finland
Morphology ultrasound screening, weeks 18+0 to 21+6 of gestation
1.6
26.9
702
4434
SGA01
NOMESCO Finland
Tooth opening as first aid
1.4
26.8
1673
12693
G47.3
ICD-10 Finland
Sleep apnoea
1.4
26.5
1286
9325
K02.1
ICD-10 Finland
Caries of dentine
1.2
26.3
6114
55049
O20.0
ICD-10 Finland
Threatened abortion
1.8
26.1
430
2367
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
1.4
25.9
1571
11848
A10BK03
ATC
empagliflozin; oral
1.9
25.3
380
2028
MBA03
NOMESCO Finland
Curettage of uterus after delivery or abortion
1.8
25.0
481
2785
MA3AE
NOMESCO Finland
Combined first trimester screening
1.6
25.0
678
4330
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.2
24.9
4186
36265
A10BJ06
ATC
semaglutide; parenteral
2.3
24.6
226
980
WX290
NOMESCO Finland
Other blockade of nerve
1.2
24.6
4983
44048
ZXD00
NOMESCO Finland
Emergency procedure
1.9
24.5
351
1837
O26.7
ICD-10 Finland
Subluxation of symphysis (pubis) in pregnancy, childbirth and the puerperium
2.5
24.1
195
792
O03.9
ICD-10 Finland
Spontaneous abortion, Complete or unspecified, without complication
1.6
23.9
677
4366
J01AA02
ATC
doxycycline; systemic
1.2
23.7
7783
72348
JKA21
NOMESCO Finland
Laparoscopic cholecystectomy
1.5
23.5
1005
7104
WX321
NOMESCO Finland
Acute spinal anesthesia for delivery
1.6
23.5
668
4314
C07FB02
ATC
metoprolol and felodipine; systemic
3.2
23.3
125
394
65000
ICD-8 Finland
Delivery without mention of complication, Occipital presentation
1.3
23.1
2015
16046
O26.6
ICD-10 Finland
Liver disorders in pregnancy, childbirth and the puerperium
2.1
23.0
259
1233
C10AA05
ATC
atorvastatin; oral
1.3
22.9
1687
13105
A10AB04
ATC
insulin lispro; parenteral (insulins and analog. for injection, fast-acting)
2.0
22.8
300
1523
SPAT1189
SPAT
Other ultrasound examination during pregnancy
1.7
22.7
518
3157
O41.1
ICD-10 Finland
Infection of amniotic sac and membranes
2.6
22.7
172
675
R03.0
ICD-10 Finland
Elevated blood-pressure reading, without diagnosis of hypertension
1.9
22.5
357
1940
O72.1
ICD-10 Finland
Other immediate postpartum haemorrhage
1.8
22.3
384
2144
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.2
22.3
5473
49155
XFP96
NOMESCO Finland
Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation
3.1
22.3
126
413
FM1QE
NOMESCO Finland
Extensive ultrasound of fetal heart
3.0
22.2
134
456
O35.8
ICD-10 Finland
Maternal care for other (suspected) fetal abnormality and damage
2.0
22.2
306
1581
Z39.1
ICD-10 Finland
Care and examination of lactating mother
1.9
22.2
329
1748
SPAT1310
SPAT
Counselling related to known health issue
1.3
22.0
2830
23679
SPAT1301
SPAT
No procedures
1.3
22.0
2614
21665
O40
ICD-10 Finland
Polyhydramnios
2.4
21.9
193
822
6423C
ICD-9 Finland
Hypertension complicating pregnancy, childbirth and the puerperium, Transient hypertension of pregnancy[HYPERTENSIO GRAVIDARUM, SYNNYTYKSEN JÄLKEEN]
+∞
21.9
21
*
6461A
ICD-9 Finland
Other complications of pregnancy, not elsewhere classified, Oedema or excessive weight gain in pregnancy, without mention of hypertension
+∞
21.9
21
*
A10AB01
ATC
insulin (human); parenteral (insulins and analog. for injection, fast-acting)
2.0
21.7
298
1538
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.2
21.6
6123
55710
O14
ICD-10 Finland
Pre-eclampsia
114.9
21.5
23
*
C09CA07
ATC
telmisartan; oral
1.8
21.5
382
2160
R51.80
ICD-10 Finland
Headache
1.3
21.3
1574
12222
O72.2
ICD-10 Finland
Delayed and secondary postpartum haemorrhage
2.0
21.3
264
1311
O36.8
ICD-10 Finland
Maternal care for other specified fetal problems
2.0
21.2
263
1304
O21.9
ICD-10 Finland
Vomiting of pregnancy, unspecified
2.2
21.1
223
1035
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.2
20.9
5024
44905
160
Kela drug reimbursment
exenatide
2.9
20.8
131
459
SGC00
NOMESCO Finland
Local medication of root channels of tooth
1.4
20.8
1085
7957
C08DB01
ATC
diltiazem; oral
2.4
20.7
185
792
WW200
SPAT
NA
1.4
20.7
981
7068
ZYC01
SPAT
NA
1.6
20.5
536
3389
Z37.0
ICD-10 Finland
Single live birth
1.3
20.5
1595
12477
W90
ICPC
Uncompl labour/delivery livebirth
1.5
20.4
702
4739
C10AA07
ATC
rosuvastatin; oral
1.4
20.4
1216
9126
R03AC02
ATC
salbutamol; inhalant
1.2
20.4
5394
48622
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
2.7
20.4
138
508
J01CA04
ATC
amoxicillin; systemic
1.3
20.1
8766
83059
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.7
20.1
472
2899
O99.5
ICD-10 Finland
Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium
2.7
20.1
142
537
Z35
ICD-10 Finland
Supervision of high-risk pregnancy
2.4
20.0
172
724
SPAT1097
SPAT
Recording of ECG
1.4
19.8
842
5942
K04.0
ICD-10 Finland
Pulpitis
1.4
19.8
1041
7644
C03BA11
ATC
indapamide; oral
2.6
19.6
145
560
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
1.8
19.6
347
1958
C09BA03
ATC
lisinopril and diuretics; oral
3.1
19.6
108
349
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.2
19.6
3694
32148
25009
ICD-8 Finland
Diabetes mellitus, Unspecified
5.4
19.3
58
108
SPAT1324
SPAT
Screening procedure
1.2
19.3
2815
23829
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
1.8
19.2
358
2055
O35.1
ICD-10 Finland
Maternal care for (suspected) chromosomal abnormality in fetus
1.8
19.2
315
1736
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.2
19.1
2627
22087
FP1B5
NOMESCO Finland
Resting ECG, 12 leads
3.4
19.0
92
270
WX234
NOMESCO Finland
Paracervical blockade
1.6
18.9
450
2776
Z3232
NOMESCO Finland
Midwife
1.3
18.8
1465
11452
LGA20
NOMESCO Finland
Sterilisation by constriction of Fallopian tubes
2.4
18.8
161
678
O36.3
ICD-10 Finland
Maternal care for signs of fetal hypoxia
3.0
18.7
111
377
A10BJ02
ATC
liraglutide; parenteral
2.5
18.7
153
626
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
1.3
18.7
2365
19687
MBA00
NOMESCO Finland
Vacuum aspiration from uterus after delivery or abortion
1.8
18.7
346
1984
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
1.7
18.6
430
2634
MBA30
NOMESCO Finland
Manual removal of placenta from delivered uterus
1.9
18.5
272
1443
O99.6
ICD-10 Finland
Diseases of the digestive system complicating pregnancy, childbirth and the puerperium
2.4
18.3
152
630
Z30.2
ICD-10 Finland
Sterilization
1.3
18.3
1262
9682
SPAT1008
SPAT
Photography of fundus of the eye or interpretation of photograph
2.2
18.2
185
846
SPAT1153
SPAT
Removal of sutures
1.3
18.1
2270
18866
O02.0
ICD-10 Finland
Blighted ovum and nonhydatidiform mole
1.6
17.9
480
3056
T82
ICPC
Obesity
1.7
17.8
390
2350
O15.0
ICD-10 Finland
Eclampsia in pregnancy
+∞
17.7
17
*
LGA10
NOMESCO Finland
Sterilisation by destruction or division of Fallopian tubes
2.5
17.7
143
583
SPAT1028
SPAT
Ultrasound examination of paranasal sinuses
1.5
17.6
620
4206
Z39.0
ICD-10 Finland
Care and examination immediately after delivery
2.2
17.5
184
853
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
1.9
17.3
256
1364
A46
ICD-10 Finland
Erysipelas
1.5
17.2
630
4311
6565A
ICD-9 Finland
Other foetal and placental problems affecting management of mother, Poor foetal growth[SIKIÖN HIDASTUNUT INTRAUTERIININ KASVU,RASK AIK]
4.2
17.1
65
156
WX110
NOMESCO Finland
Local anesthesy
1.2
17.1
7172
66927
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.5
17.0
629
4309
25000
ICD-8 Finland
Diabetes mellitus, Sine complicatione
2.3
17.0
157
684
A10BK01
ATC
dapagliflozin; oral
2.0
16.9
228
1170
O61.8
ICD-10 Finland
Other failed induction of labour
4.6
16.7
57
123
O82.11
ICD-10 Finland
Childbirth with an emergency caesarean section in an emergency
2.2
16.7
176
819
C07AB05
ATC
betaxolol; oral
2.7
16.5
113
422
C02LM02
ATC
NA
5.8
16.5
46
79
M04AA01
ATC
allopurinol; systemic
1.7
16.4
334
1971
SAA01
NOMESCO Finland
Simple examination of mouth
1.2
16.4
7620
71611
QBJ30
NOMESCO Finland
Correction of abdominal apron
2.5
16.3
125
496
C10AX09
ATC
ezetimibe; oral
1.6
16.3
428
2712
SPAT1200
SPAT
Guidance for breast-feeding and breast care
1.6
16.3
416
2618
O64.0
ICD-10 Finland
Obstructed labour due to incomplete rotation of fetal head
1.7
16.2
318
1859
A02BC01
ATC
omeprazole; systemic
1.2
16.2
2120
17679
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.3
16.0
1043
7924
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.2
16.0
2726
23376
SGB30
NOMESCO Finland
Other demanding filling of root channel of tooth
1.3
16.0
1193
9256
R09
ICPC
Sinus symptom/complaint
1.4
15.9
889
6591
G02BA03
ATC
plastic IUD with progestogen
1.3
15.8
1917
15833
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.2
15.8
5563
50941
ACC51
NOMESCO Finland
Release of median nerve
1.5
15.8
599
4132
A10BX04
ATC
[U] exenatide; parenteral
3.4
15.7
74
215
Z35.4
ICD-10 Finland
Supervision of pregnancy with grand multiparity
2.5
15.6
124
503
Z36.8
ICD-10 Finland
Other antenatal screening
1.7
15.6
321
1902
C07AB04
ATC
acebutolol; systemic
3.8
15.5
65
171
J45.9
ICD-10 Finland
Asthma, unspecified
1.3
15.5
1408
11221
O86.0
ICD-10 Finland
Infection of obstetric surgical wound
2.3
15.4
144
634
6488A
ICD-9 Finland
Other current conditions in the mother classifiable elsewhere but complicating pregnancy, childbirth and the puerperium, Abnormal glucose tolerance
2.1
15.4
165
774
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.2
15.4
4153
37139
M54.5
ICD-10 Finland
Low back pain
1.2
15.3
3126
27252
I11.9
ICD-10 Finland
Hypertensive heart disease without (congestive) heart failure
2.4
15.3
128
532
H02AB06
ATC
prednisolone; systemic
1.2
15.2
4014
35821
SGC10
NOMESCO Finland
Covering pulpa of tooth
1.3
15.1
962
7281
O61.1
ICD-10 Finland
Failed instrumental induction of labour
4.0
15.0
60
152
C03DA01
ATC
spironolactone; oral
1.5
15.0
464
3063
C09DB01
ATC
valsartan and amlodipine; oral
2.4
14.9
125
522
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.2
14.7
3571
31608
C02DE04
ATC
NA
4.0
14.6
58
146
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.3
14.6
1452
11701
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
0.2
14.5
18
781
A10BB12
ATC
glimepiride; oral
2.0
14.5
188
957
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.2
14.4
2639
22746
SGA04
NOMESCO Finland
Very demanding opening and dilatation of root canal of tooth
1.3
14.4
1083
8405
O99.4
ICD-10 Finland
Diseases of the circulatory system complicating pregnancy, childbirth and the puerperium
2.7
14.4
95
349
310
Kela drug reimbursment
Orlistat, sibutramine and other major and expensive medicines used to treat obesity
3.0
14.4
83
279
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.4
14.3
813
6040
AN1
HP
Coronary angiography
1.7
14.3
291
1721
N02AJ06
ATC
codeine and paracetamol; systemic
1.2
14.2
3270
28790
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.4
14.0
638
4559
B01AB04
ATC
dalteparin; parenteral
1.7
14.0
309
1868
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.3
14.0
1395
11246
FM1NE
NOMESCO Finland
Ultrasound examination of fetal heart
2.9
13.9
82
281
B02AA02
ATC
tranexamic acid; systemic
1.2
13.8
1786
14842
H04AA01
ATC
glucagon; nasal, parenteral
1.9
13.8
213
1156
J01FF01
ATC
clindamycin; systemic
1.2
13.7
2210
18803
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
2.1
13.6
157
762
2500B
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]
1.9
13.6
188
980
O84.2
ICD-10 Finland
Multiple delivery, all by caesarean section
2.9
13.6
81
279
TMW99
NOMESCO Finland
Other minor surgical procedure in obstetrics
2.2
13.5
134
609
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.2
13.5
5071
46419
SGA02
NOMESCO Finland
Opening and dilatation of root canal of tooth
1.3
13.5
1057
8246
63710
ICD-8 Finland
Pre-eclampsia, eclampsia and toxaemia, unspecified, Eclampsia
+∞
13.5
13
*
N05AH02
ATC
clozapine; systemic
0.3
13.3
26
886
K04.08
ICD-10 Finland
Other specified pulpit
1.4
13.2
648
4698
N05AH03
ATC
olanzapine; systemic
0.6
13.2
225
3609
TPH04
NOMESCO Finland
Cathetrisation of vein
1.3
13.1
1395
11325
A10AA02
ATC
NA
1.8
13.0
220
1229
C07BB02
ATC
metoprolol and thiazides; systemic
3.2
13.0
68
215
W27
ICPC
Fear of complications of pregnancy
2.0
13.0
157
778
F29
ICD-10 Finland
Unspecified nonorganic psychosis
0.5
13.0
118
2221
ACC59
NOMESCO Finland
Decompression and freeing of adhesions of peripheral nerve: other or unspecified
1.6
12.9
302
1860
P01AB01
ATC
metronidazole; oral, rectal
1.2
12.9
4149
37474
G43.9
ICD-10 Finland
Migraine, unspecified
1.4
12.8
753
5626
J03.0
ICD-10 Finland
Streptococcal tonsillitis
1.6
12.8
326
2056
O20.8
ICD-10 Finland
Other haemorrhage in early pregnancy
2.5
12.8
97
388
O72.0
ICD-10 Finland
Third-stage haemorrhage
1.6
12.7
311
1937
C08CA10
ATC
nilvadipine; oral
2.8
12.7
80
286
O85
ICD-10 Finland
Puerperal sepsis
2.1
12.7
145
701
N71.0
ICD-10 Finland
Acute inflammatory disease of uterus
1.5
12.7
392
2587
Z32.0
ICD-10 Finland
Pregnancy, not (yet) confirmed
1.6
12.7
360
2331
R03BA05
ATC
fluticasone; inhalant
1.2
12.7
1631
13538
SPAT1283
SPAT
Restricted health certificate
1.2
12.6
2345
20197
C09DX01
ATC
valsartan, amlodipine and hydrochlorothiazide; oral
2.9
12.6
76
265
O32.2
ICD-10 Finland
Maternal care for transverse and oblique lie
2.3
12.6
113
490
G03GA01
ATC
chorionic gonadotrophin; parenteral
1.4
12.6
605
4371
T89
ICPC
Diabetes insulin dependent
1.7
12.5
274
1659
O10
ICD-10 Finland
Pre-existing hypertension complicating pregnancy, childbirth and the puerperium
+∞
12.5
12
*
63709
ICD-8 Finland
Pre-eclampsia, eclampsia and toxaemia, unspecified, Prae-eclampsia NUD
+∞
12.5
12
*
A10AA01
ATC
NA
1.8
12.4
211
1185
M79.6
ICD-10 Finland
Pain in limb
1.2
12.4
3121
27614
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.4
12.3
718
5356
C09AA01
ATC
captopril; oral
3.8
12.3
50
130
A10BX07
ATC
[U] liraglutide; parenteral
2.8
12.3
76
268
G03GB02
ATC
clomifene; oral
1.6
12.2
292
1812
C09DA07
ATC
telmisartan and diuretics; oral
1.8
12.1
197
1087
E66.0
ICD-10 Finland
Obesity due to excess calories
2.7
12.1
81
301
O63.1
ICD-10 Finland
Prolonged second stage (of labour)
1.5
12.1
415
2807
K04.09
ICD-10 Finland
Pulpit UNS
1.5
12.1
388
2585
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
0.7
12.1
296
4403
R07.4
ICD-10 Finland
Chest pain, unspecified
1.2
11.9
1587
13211
Z30.1
ICD-10 Finland
Insertion of (intrauterine) contraceptive device
1.2
11.9
1868
15821
O99.1
ICD-10 Finland
Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium
2.2
11.9
114
511
O03.4
ICD-10 Finland
Spontaneous abortion, Incomplete, without complication
1.6
11.9
313
1990
C02EA03
ATC
NA
4.0
11.9
46
115
8221
FHL
Sterilization of the laparotomy pathway
1.7
11.8
238
1404
O47.9
ICD-10 Finland
False labour, unspecified
1.7
11.7
235
1388
H3600, E103
ICD-10 Finland
NA
2.3
11.6
104
451
SAA02
NOMESCO Finland
Basic examination of mouth
1.2
11.6
6989
65927
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.2
11.4
2892
25571
C08CA03
ATC
isradipine; systemic
3.5
11.4
52
150
H66.0
ICD-10 Finland
Acute suppurative otitis media
1.4
11.3
579
4230
O21.0
ICD-10 Finland
Mild hyperemesis gravidarum
1.9
11.3
150
774
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
1.3
11.2
807
6220
OAA41
SPAT
NA
2.1
11.2
122
580
SPAT1260
SPAT
Consultation of another employee
1.2
11.2
1356
11169
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.1
11.1
5131
47419
C01DA14
ATC
isosorbide mononitrate; oral
1.6
11.1
281
1767
6480A
ICD-9 Finland
Other current conditions in the mother classifiable elsewhere but complicating pregnancy, childbirth and the puerperium, Diabetes mellitus
2.7
11.1
72
265
SPAT1315
SPAT
Periodic health check-up of children and adolescents
1.5
11.1
421
2909
E11.3
ICD-10 Finland
Type 2 diabetes mellitus, with ophthalmic complications
2.3
11.0
97
420
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.4
10.9
453
3189
O45.9
ICD-10 Finland
Premature separation of placenta, unspecified
3.2
10.9
56
177
SPAT1193
SPAT
Pap smear
1.2
10.8
1468
12244
ZXH06
SPAT
NA
1.8
10.7
183
1032
SPAT1312
SPAT
General health counselling
1.2
10.7
2913
25878
N02AX02
ATC
tramadol; systemic, rectal
1.2
10.6
3069
27377
MA3AE
SPAT
NA
2.7
10.6
69
254
O47
ICD-10 Finland
False labour
2.0
10.6
127
628
O30.00
ICD-10 Finland
Twin pregnancy with separate amniotic and chorionic sacs
2.7
10.6
68
249
SPAT1292
SPAT
Other function in accordance with SHToL (Finnish classification of nursing interventions)
1.4
10.5
472
3369
MBA04
NOMESCO Finland
Curettage of uterus after delivery
2.3
10.5
97
430
I15.9
ICD-10 Finland
Secondary hypertension, unspecified
3.3
10.5
52
160
H66.9
ICD-10 Finland
Otitis media, unspecified
1.4
10.5
492
3540
SPAT1388
SPAT
Extensive health check-up based on individual need
2.9
10.5
61
209
O36.4
ICD-10 Finland
Maternal care for intrauterine death
2.4
10.4
82
336
O80.9
ICD-10 Finland
Single spontaneous delivery, unspecified
1.9
10.4
155
832
O46.9
ICD-10 Finland
Antepartum haemorrhage, unspecified
1.6
10.4
251
1560
Y4300
ICD-8 Finland
Preventive sterilization, Legal sterilization, medical reasons (illness or physical injury)
2.1
10.4
117
567
C09AA04
ATC
perindopril; oral
1.7
10.4
191
1101
F20.9
ICD-10 Finland
Schizophrenia, unspecified
0.3
10.4
29
832
F20.30
ICD-10 Finland
Undifferentiated schizophrenia continuous
0.2
10.3
15
597
I50.9
ICD-10 Finland
Heart failure, unspecified
1.6
10.3
247
1536
-1
NOMESCO Finland
NA
1.2
10.3
3345
30092
C07AB12
ATC
nebivolol; oral
1.8
10.3
173
969
V230A
ICD-9 Finland
Supervision of high-risk pregnancy, Pregnancy with history of infertility
2.1
10.2
106
496
O99.0
ICD-10 Finland
Anaemia complicating pregnancy, childbirth and the puerperium
1.9
10.2
139
724
J01FA01
ATC
erythromycin; systemic
1.2
10.2
1549
13060
R75
ICPC
Sinusitis acute/chronic
1.4
10.1
468
3360
O73.0
ICD-10 Finland
Retained placenta without haemorrhage
2.0
10.1
130
662
N97.9
ICD-10 Finland
Female infertility, unspecified
1.3
10.1
823
6455
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.2
10.0
1582
13385
MAB10
NOMESCO Finland
External version
2.1
10.0
106
500
OAA12
SPAT
NA
1.7
10.0
194
1140
KMAK
NOMESCO Finland
NA
1.1
9.8
5711
53420
J01CE02
ATC
phenoxymethylpenicillin; oral
1.1
9.7
7253
68945
M10.9
ICD-10 Finland
Gout, unspecified
1.9
9.7
137
722
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.4
9.7
430
3066
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
2.6
9.7
67
257
O28.3
ICD-10 Finland
Abnormal ultrasonic finding on antenatal screening of mother
2.1
9.7
107
516
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
1.3
9.7
865
6868
G03DA04
ATC
progesterone; systemic, rectal, vaginal
1.4
9.7
400
2815
J01FA06
ATC
roxithromycin; oral
1.1
9.6
3715
33798
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.1
9.6
4026
36828
OAB42
SPAT
NA
1.5
9.6
361
2493
162
Kela drug reimbursment
liraglutide
2.7
9.6
63
235
MAW96
NOMESCO Finland
Other operation in pregnancy or at delivery
2.1
9.6
103
490
O23.5
ICD-10 Finland
Infections of the genital tract in pregnancy
1.9
9.6
132
694
WYA50
NOMESCO Finland
Student oral health check consistent with decree to assess need for oral health guidance and services
0.5
9.5
88
1643
WZC30
NOMESCO Finland
Teaching
1.3
9.5
833
6600
R01AD09
ATC
mometasone; nasal
1.1
9.5
4807
44526
A10AD05
ATC
insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)
3.0
9.5
51
168
A10BJ01
ATC
exenatide; parenteral
2.8
9.4
57
202
XCK10
NOMESCO Finland
Photography of fundus of eye
1.4
9.4
489
3584
C02DE10
ATC
NA
4.3
9.4
33
76
WX725
NOMESCO Finland
Noninvasive ventilation
1.5
9.4
301
2005
H36.00
ICD-10 Finland
Diabetic background retinopathy
2.3
9.4
85
375
R3110
NOMESCO Finland
Psychosocial training
1.6
9.4
211
1288
CK2S4
SPAT
NA
3.2
9.4
48
152
KAY40
NOMESCO Finland
NA
0.5
9.4
93
1706
Z71.8
ICD-10 Finland
Other specified counselling
1.2
9.4
2289
20120
OAA11
SPAT
NA
1.5
9.4
330
2247
O15.1
ICD-10 Finland
Eclampsia in labour
+∞
9.4
9
*
MBC30
NOMESCO Finland
Repair of partial rupture of perineum
1.6
9.3
255
1641
MBA96
NOMESCO Finland
Other removal of retained products of conception after delivery or abortion
1.5
9.3
278
1827
O42.9
ICD-10 Finland
Premature rupture of membranes, unspecified
1.4
9.3
458
3328
A10BD07
ATC
metformin and sitagliptin; systemic
1.8
9.2
162
922
Z11.3
ICD-10 Finland
Special screening examination for infections with a predominantly sexual mode of transmission
0.7
9.2
399
5379
N92.0
ICD-10 Finland
Excessive and frequent menstruation with regular cycle
1.2
9.2
1265
10556
O70.1
ICD-10 Finland
Second degree perineal laceration during delivery
1.5
9.2
339
2332
J01FA10
ATC
azithromycin; systemic
1.1
9.1
6292
59363
K04.1
ICD-10 Finland
Necrosis of pulp
1.3
9.1
864
6911
SGB20
NOMESCO Finland
Filling of root of tooth with 2 root channels
1.3
9.1
558
4200
R02
ICPC
Shortness of breath/dyspnoea
1.3
9.1
781
6169
O68.2
ICD-10 Finland
Labour and delivery complicated by fetal heart rate anomaly with meconium in amniotic fluid
2.1
9.1
102
496
LCA16
NOMESCO Finland
Destruction of endometrium
1.7
9.1
180
1064
G03FA01
ATC
norethisterone and estrogen; systemic (progestogens and estrogens, fixed comb.)
0.8
9.0
602
7656
MBC10
NOMESCO Finland
Repair of obstetric laceration of vagina
1.6
9.0
244
1565
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
1.9
9.0
130
696
WX704
NOMESCO Finland
Intubation
1.4
9.0
514
3828
6468B
ICD-9 Finland
Other complications of pregnancy, not elsewhere classified, Other specified complications of pregnancy[RASKAUDENAIKAINEN LIIKALIHAVUUS]
9.0
9.0
18
20
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.2
9.0
1415
11966
Z34
ICD-10 Finland
Supervision of normal pregnancy
1.3
9.0
652
5034
MWE00
NOMESCO Finland
Reoperation for deep haemorrhage in obstetric surgery
4.0
9.0
34
85
SPAT1192
SPAT
Gynaecological examination
1.2
9.0
1451
12303
I11.0
ICD-10 Finland
Hypertensive heart disease with (congestive) heart failure
3.0
8.9
49
164
O36.9
ICD-10 Finland
Maternal care for fetal problem, unspecified
1.9
8.8
126
670
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.2
8.8
1010
8259
B01AC04
ATC
clopidogrel; oral
1.4
8.8
383
2720
O47.1
ICD-10 Finland
False labour at or after 37 completed weeks of gestation
1.4
8.8
502
3737
A10AE06
ATC
insulin degludec; parenteral
1.7
8.8
188
1138
KAY20
NOMESCO Finland
NA
0.5
8.8
66
1307
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
1.3
8.8
772
6120
SPAT1316
SPAT
Extensive health check-up of children and adolescents
1.5
8.7
332
2297
BEF00
NOMESCO Finland
Continuous subcutaneous glucose monitoring
2.3
8.7
76
330
FN2BA
NOMESCO Finland
Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)
1.9
8.7
127
683
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.2
8.7
2635
23534
N05AA02
ATC
levomepromazine; systemic
0.6
8.7
93
1665
WYA40
NOMESCO Finland
Assessment of oral health and treatment needs for family expecting first child
1.6
8.7
231
1481
AA1AD
NOMESCO Finland
CT of head and brain
1.2
8.6
1222
10222
J03.9
ICD-10 Finland
Acute tonsillitis, unspecified
1.3
8.6
532
4017
SPAT1081
SPAT
Cardiorespiratory global assessment
1.5
8.5
245
1598
O34.1
ICD-10 Finland
Maternal care for tumour of corpus uteri
2.3
8.5
73
316
A10BB01
ATC
glibenclamide; oral
2.6
8.5
59
228
J45.0
ICD-10 Finland
Predominantly allergic asthma
1.3
8.5
758
6018
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.1
8.4
3123
28272
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.2
8.4
1439
12255
I35.0
ICD-10 Finland
Aortic (valve) stenosis
1.9
8.4
115
605
SPAT1255
SPAT
Intravenous administration of medicine
1.4
8.4
362
2568
SPAT1246
SPAT
Screening of depression or other psychiatric problem
1.3
8.4
539
4089
O04.6
ICD-10 Finland
Medical abortion, complete or unspecified, complicated by delayed or excessive haemorrhage
1.8
8.4
145
824
WX600
NOMESCO Finland
Single shot through catheter
1.6
8.4
232
1499
SPAT1240
SPAT
Therapeutic discussion
1.2
8.4
1157
9657
C09BB04
ATC
perindopril and amlodipine; systemic
2.5
8.4
62
249
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.2
8.3
913
7429
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.3
8.3
554
4225
SPAT1190
SPAT
Insertion or removal of intrauterine contraceptive device
1.2
8.3
879
7126
I20.00
ICD-10 Finland
Unstable angina
2.5
8.3
64
261
MA5AE
SPAT
NA
2.5
8.3
64
261
O35.9
ICD-10 Finland
Maternal care for (suspected) fetal abnormality and damage, unspecified
1.8
8.2
137
771
SPAT1285
SPAT
Provision of consultation response
1.4
8.2
344
2430
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
1.7
8.2
155
907
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
1.3
8.2
611
4739
WX720
NOMESCO Finland
Own respiration
1.5
8.1
228
1478
TDM10
NOMESCO Finland
Puncture of maxillary antrum
1.5
8.1
308
2134
C09BB05
ATC
ramipril and felodipine; oral
5.6
8.1
22
39
6565B
ICD-9 Finland
Other foetal and placental problems affecting management of mother, Poor foetal growth[SIKIÖN HIDASTUNUT INTRAUTERIININ KASVU,SYNN AIK]
3.8
8.1
32
84
R21
ICPC
Throat symptom/complaint
1.2
8.1
2252
19976
C02DB01
ATC
dihydralazine; systemic
17.1
8.0
12
7
SPAT1195
SPAT
Antenatal classes
1.4
8.0
410
3000
N05AX12
ATC
aripiprazole; systemic
0.7
8.0
174
2643
O21
ICD-10 Finland
Excessive vomiting in pregnancy
2.0
8.0
101
516
TPH07
NOMESCO Finland
Cathetrisation of artery
1.4
8.0
455
3389
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.2
8.0
2430
21686
O68.3
ICD-10 Finland
Labour and delivery complicated by biochemical evidence of fetal stress
2.1
8.0
89
433
A03
ICPC
Fever
1.2
8.0
1569
13534
A10BG03
ATC
pioglitazone; oral
2.1
7.9
87
421
P72
ICPC
Schizophrenia
0.4
7.9
29
741
J45.1
ICD-10 Finland
Nonallergic asthma
1.4
7.9
447
3325
R03BA02
ATC
budesonide; inhalant
1.2
7.9
1488
12782
C03EA02
ATC
trichlormethiazide and potassium-sparing agents; oral
2.3
7.9
71
314
Z95.1
ICD-10 Finland
Presence of aortocoronary bypass graft
2.7
7.9
51
189
M01AE01
ATC
ibuprofen; systemic, rectal
1.2
7.9
9770
95324
A10BH02
ATC
vildagliptin; oral
2.4
7.9
63
264
SPAT1100
SPAT
Long-term monitoring of blood pressure
1.5
7.9
239
1580
O28.1
ICD-10 Finland
Abnormal biochemical finding on antenatal screening of mother
2.1
7.9
81
380
SGB10
NOMESCO Finland
Fiiling of rooth of tooth with one root channel
1.2
7.8
868
7075
R5140
NOMESCO Finland
Monitoring the use of the aid
1.3
7.8
493
3731
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
1.4
7.8
303
2108
R74
ICPC
Upper respiratory infection acute
1.1
7.8
3335
30443
W03
ICPC
Antepartum bleeding
1.9
7.8
105
548
G03FB05
ATC
norethisterone and estrogen; systemic (progestogens and estrogens, sequential prep.)
0.8
7.8
496
6341
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.2
7.8
1083
9045
N02AA05
ATC
oxycodone; systemic
1.3
7.8
612
4779
R73.0
ICD-10 Finland
Abnormal glucose tolerance test
1.8
7.8
123
680
C07FB03
ATC
atenolol and nifedipine; systemic
9.4
7.7
15
16
SPAT1377
SPAT
Polysomnography
1.5
7.7
217
1411
JJA21
NOMESCO Finland
Laparoscopic biopsy of liver
3.5
7.7
34
98
PEF23
NOMESCO Finland
Thrombendarterectomy of femoral artery
4.0
7.7
29
73
CKC12
NOMESCO Finland
Photocoagulation of retina
1.5
7.7
220
1436
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.2
7.7
1786
15613
MA4AT
NOMESCO Finland
Chorion biopsy with ultrasound guidance
2.0
7.7
96
489
H03AA01
ATC
levothyroxine sodium; systemic
1.2
7.7
2189
19436
WX892
NOMESCO Finland
Monitored bed care
1.4
7.7
350
2513
F53.0
ICD-10 Finland
Mild mental and behavioural disorders associated with the puerperium, not elsewhere classified
3.1
7.6
40
131
177
Kela drug reimbursment
Insulin glargine 300 U / ml
1.8
7.6
114
620
MAB20
NOMESCO Finland
Failed external version
1.7
7.6
163
990
A08AB01
ATC
orlistat; oral
2.9
7.6
44
152
SPAT1236
SPAT
Informing family of child’s disability
1.8
7.6
123
685
J01CA08
ATC
pivmecillinam; oral
1.1
7.6
5030
47115
MAC00
NOMESCO Finland
Rupture of amniotic membrane
2.4
7.6
60
250
Z35.5
ICD-10 Finland
Supervision of elderly primigravida
2.1
7.6
77
362
XMA20
NOMESCO Finland
Early examination of pregnancy
1.7
7.6
162
981
K80.5
ICD-10 Finland
Calculus of bile duct without cholangitis or cholecystitis
1.6
7.6
167
1021
M54.4
ICD-10 Finland
Lumbago with sciatica
1.2
7.5
1352
11565
SPAT1391
SPAT
Counselling and guidance related to family situation
1.7
7.5
145
856
MAC02
NOMESCO Finland
Rupture of aminiotic membrane for advancement of labor
2.3
7.5
68
302
O90.2
ICD-10 Finland
Haematoma of obstetric wound
3.6
7.5
32
90
SGA03
NOMESCO Finland
Demanding opening and dilatation of root canal of tooth
1.2
7.5
834
6803
E78.9
ICD-10 Finland
Disorder of lipoprotein metabolism, unspecified
1.8
7.5
115
633
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.3
7.5
453
3412
A10AD01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)
1.9
7.4
100
523
WX780
NOMESCO Finland
Remote monitoring CPAP
1.6
7.4
203
1314
E10.1
ICD-10 Finland
Type 1 diabetes mellitus, With ketoacidosis
2.0
7.4
89
446
R06.5
ICD-10 Finland
Mouth breathing
1.3
7.4
479
3642
6563B
ICD-9 Finland
Other foetal and placental problems affecting management of mother, Foetal distress[ASPHYXIA FOETALIS, SYNNYTYKSEN AIKANA]
1.6
7.4
164
1007
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
1.2
7.4
2022
17897
O84.8
ICD-10 Finland
Other multiple delivery
2.7
7.4
48
180
D10BA01
ATC
isotretinoin; oral
0.8
7.4
446
5736
C10AA04
ATC
fluvastatin; oral
1.5
7.3
249
1687
G03FA12
ATC
medroxyprogesterone and estrogen; systemic (progestogens and estrogens, fixed comb.)
0.7
7.3
196
2855
-2
ICD-10 Finland
NA
0.6
7.3
81
1435
G03GA05
ATC
follitropin alfa; parenteral
1.4
7.3
396
2930
O10.3
ICD-10 Finland
Pre-existing hypertensive heart and renal disease complicating pregnancy, childbirth and the puerperium
+∞
7.3
7
*
6427A
ICD-9 Finland
Hypertension complicating pregnancy, childbirth and the puerperium, Pre-eclampsia or eclampsia superimposed on pre-existing hypertension[PRAE-ECL SEU ECL CUM HYPERT ART,ENNEN SYNNYTYSTÄ]
+∞
7.3
7
*
O12
ICD-10 Finland
Gestational [pregnancy-induced] oedema and proteinuria without hypertension
+∞
7.3
7
*
I50.0
ICD-10 Finland
Congestive heart failure
1.8
7.3
109
593
N05AX08
ATC
risperidone; systemic
0.7
7.2
241
3385
O03.1
ICD-10 Finland
Spontaneous abortion, Incomplete, complicated by delayed or excessive haemorrhage
1.5
7.2
201
1307
C09AA06
ATC
quinapril; systemic
4.0
7.2
27
68
W05
ICPC
Pregnancy vomiting/nausea
1.8
7.2
114
631
63501
ICD-8 Finland
Urinary infections arising during pregnancy and the puerperium, Pyelitis et pyelocystitis
3.7
7.2
29
78
W18
ICPC
Post-partum symptom/complaint other
2.1
7.2
79
385
R06.0
ICD-10 Finland
Dyspnoea
1.2
7.2
1587
13818
I25.0
ICD-10 Finland
Atherosclerotic cardiovascular disease, so described
1.9
7.2
96
503
JDF01
NOMESCO Finland
Laparoscopic gastroplasty
2.3
7.2
60
257
R42
ICD-10 Finland
Dizziness and giddiness
1.2
7.1
1400
12064
WX322
NOMESCO Finland
Combined spinal-epidural analgesia in obstetrics
1.5
7.1
236
1592
H3601, E113
ICD-10 Finland
NA
2.7
7.1
44
161
SPAT1373
SPAT
Combined screening in early pregnancy
1.5
7.1
230
1543
C02DE02
ATC
NA
3.5
7.1
31
89
C03EB01
ATC
furosemide and potassium-sparing agents; systemic
1.8
7.1
119
672
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.3
7.1
474
3623
K04.4
ICD-10 Finland
Acute apical periodontitis of pulpal origin
1.3
7.1
647
5156
F25.9
ICD-10 Finland
Schizoaffective disorder, unspecified
0.4
7.1
24
632
I20.01
ICD-10 Finland
Unstable angina
2.5
7.1
51
204
Q61.2
ICD-10 Finland
Polycystic kidney, autosomal dominant
3.2
7.1
35
111
EBA00
NOMESCO Finland
Extraction of tooth
1.1
7.1
2653
23995
B01AA03
ATC
warfarin; systemic
1.3
7.1
527
4093
S18
ICPC
Laceration/cut
1.1
7.0
2859
25982
63499
ICD-8 Finland
Other complications of pregnancy, Other
1.8
7.0
109
603
SPAT1325
SPAT
Vaccination
1.1
7.0
2328
20882
SPAT1054
SPAT
Examination of peripheral nervous system
2.1
7.0
72
339
A10BX01
ATC
guar gum; systemic
1.7
7.0
141
842
R03DC03
ATC
montelukast; oral
1.2
6.9
1473
12777
E11.4
ICD-10 Finland
Type 2 diabetes mellitus, with neurological complications
2.5
6.9
52
210
H3601, E103
ICD-10 Finland
NA
2.2
6.9
69
321
F25.10
ICD-10 Finland
Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms
0.2
6.9
8
356
O62.0
ICD-10 Finland
Primary inadequate contractions
2.1
6.8
74
358
H01
ICPC
Ear pain/earache
1.2
6.8
946
7896
R2110
NOMESCO Finland
Giving the first information
1.2
6.8
721
5846
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
2.0
6.8
76
372
D68.8
ICD-10 Finland
Other specified coagulation defects
1.9
6.8
95
505
PEN23
NOMESCO Finland
Plastic repair of femoral artery
4.8
6.8
21
44
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.3
6.8
581
4591
N03AX12
ATC
gabapentin; oral
1.2
6.8
1091
9236
O75.3
ICD-10 Finland
Other infection during labour
3.3
6.8
31
93
K22
ICPC
Risk factor cardiovascular disease
1.5
6.8
205
1361
I20.81
ICD-10 Finland
Other angina pectoris stenosed coronary artery
1.8
6.7
108
601
FNA01
NOMESCO Finland
Anastomosis to coronary artery from internal mammary artery, one distal anastamosis
2.4
6.7
52
216
MBA40
NOMESCO Finland
Pharmacological evacuation of uterus after abortion
1.5
6.7
198
1302
WZC30
SPAT
NA
1.7
6.7
117
670
Z12
ICPC
Relationship problem with partner
1.5
6.7
193
1266
W30
ICPC
Pregnancy, Medical examin/health eval complete
1.9
6.7
86
446
H36.09*E10.3
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic retinopathy
2.1
6.6
70
338
O90.0
ICD-10 Finland
Disruption of caesarean section wound
3.5
6.5
28
80
G03DB01
ATC
dydrogesterone; oral
1.2
6.5
1759
15539
I87.2
ICD-10 Finland
Venous insufficiency (chronic)(peripheral)
1.2
6.5
656
5297
J01
ICD-10 Finland
Acute sinusitis
1.3
6.5
480
3727
EMB10
NOMESCO Finland
Tonsillectomy
1.3
6.5
646
5207
K02
ICD-10 Finland
Dental caries
1.3
6.4
546
4315
H3603, E103
ICD-10 Finland
NA
2.0
6.4
75
373
E11.6
ICD-10 Finland
Type 2 diabetes mellitus, with other specified complications
2.4
6.4
50
209
SPAT1187
SPAT
General ultrasound examination in early pregnancy
1.7
6.4
123
726
SPAT1303
SPAT
Counselling and guidance related to growth and development
1.8
6.4
105
593
R03AK07
ATC
formoterol and budesonide; inhalant
1.2
6.4
1659
14624
LCA06
NOMESCO Finland
Biopsy of endometrium
1.2
6.3
1365
11852
SPAT1307
SPAT
Psychosocial counselling and guidance
1.3
6.3
642
5181
D07AC13
ATC
mometasone; topical
1.1
6.3
2394
21643
ZXE10
NOMESCO Finland
More than one and less than three hours
1.1
6.3
2808
25635
M54.3
ICD-10 Finland
Sciatica
1.3
6.3
391
2961
C09BA05
ATC
ramipril and diuretics; oral
2.0
6.3
74
371
O23.4
ICD-10 Finland
Unspecified infection of urinary tract in pregnancy
2.9
6.3
34
116
Z63.7
ICD-10 Finland
Other stressful life events affecting family and household
1.6
6.3
149
934
SPAT1383
SPAT
Extensive health check-up at 4 years of age
1.7
6.3
122
724
K42.9
ICD-10 Finland
Umbilical hernia without obstruction or gangrene
1.5
6.3
228
1572
207
Kela drug reimbursment
Chronic arrhythmias
1.4
6.3
328
2418
6422X
ICD-9 Finland
Hypertension complicating pregnancy, childbirth and the puerperium, Other pre-existing hypertension complicating pregnancy, childbirth and the puerperium
+∞
6.2
6
*
XF600
NOMESCO Finland
Bloodpressure measurement
1.4
6.2
329
2426
J01.9
ICD-10 Finland
Acute sinusitis, unspecified
1.4
6.2
325
2393
ZY010
SPAT
NA
2.1
6.2
65
312
W99
ICPC
Disorder of pregn/delivery other
2.3
6.2
54
238
SFC92
NOMESCO Finland
Other demanding adjuvant procedure of filling therapy
1.3
6.2
384
2906
N97.0
ICD-10 Finland
Female infertility associated with anovulation
1.4
6.2
271
1938
NGB20
NOMESCO Finland
Primary total prosthetic replacement of knee joint without patellar part
1.3
6.2
394
2997
E28.2
ICD-10 Finland
Polycystic ovarian syndrome
1.5
6.2
193
1290
213
Kela drug reimbursment
Fat metabolism disorder associated with chronic coronary artery disease
1.9
6.2
84
446
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
1.1
6.1
1760
15615
O75.0
ICD-10 Finland
Maternal distress during labour and delivery
1.6
6.1
148
933
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
1.3
6.1
392
2981
O03
ICD-10 Finland
Spontaneous abortion
2.0
6.1
73
369
Z29
ICPC
Social problem NOS
1.6
6.1
154
982
I21.49
ICD-10 Finland
Acute subendocardial infarction unspecified coronary artery status
1.7
6.1
108
623
O28.0
ICD-10 Finland
Abnormal haematological finding on antenatal screening of mother
3.1
6.1
30
96
XMA00
NOMESCO Finland
NA
2.0
6.1
71
357
H36.01
ICD-10 Finland
Diabetic maculopathy
2.2
6.1
54
242
H01CA02
ATC
nafarelin; nasal
1.3
6.1
357
2680
Z30.5
ICD-10 Finland
Surveillance of (intrauterine) contraceptive device
1.2
6.1
905
7613
ZYC01
NOMESCO Finland
Remote contact by phone
1.4
6.1
329
2442
E11.1
ICD-10 Finland
Type 2 diabetes mellitus, with ketoacidosis
3.0
6.1
31
102
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
1.1
6.0
5719
54324
P02
ICPC
Acute stress reaction
1.3
6.0
507
4000
ZXA10
NOMESCO Finland
Bilateral
1.2
6.0
1176
10130
64399
ICD-8 Finland
Spontaneous abortion, Without mention of sepsis or toxaemia
1.4
6.0
228
1584
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.2
6.0
956
8087
C02EA05
ATC
NA
4.9
6.0
18
37
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
1.3
6.0
413
3174
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3020682) Albumin/Creatinine [Ratio] in Urine
3481
18860
2.17
295.35
4.0
3.8
mg/mmol
13.0
7.0
8.88
2388
11071
(3012516) Albumin [Mass/volume] in Urine
3362
18021
2.18
292.72
3.3
3.2
mg/l
288.8
552.1
3.18
2298
10346
(3009508) Creatinine [Moles/volume] in Urine
3672
22093
1.94
222.12
3.2
3.0
mmol/l
11.2
7.2
0.53
3293
18859
(3026493) Urate [Moles/volume] in Serum or Plasma
3489
21228
1.89
200.17
2.6
2.0
umol/l
1622.4
2757.3
2.17
3164
18794
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
1432
7084
2.15
142.82
3.5
3.9
u/l
225.2
231.4
1.32
1365
6697
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
1229
6168
2.10
116.85
1.9
1.8
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
1340
7028
2.01
112.76
1.6
1.5
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
603
2471
2.51
92.20
2.6
1.7
g/l
1.2
1.5
9.23
541
2117
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
987
5057
2.03
87.71
1.5
1.4
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
2188
14554
1.61
79.81
1.5
1.5
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
2371
16268
1.56
75.18
2.1
2.0
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
10990
101747
1.71
73.23
11.7
10.3
mmol/l
3.9
3.9
3.58
10780
98777
(3019550) Sodium [Moles/volume] in Serum or Plasma
10964
101448
1.70
73.13
11.5
10.2
mmol/l
139.5
139.6
8.72
10767
98745
(3013826) Glucose [Moles/volume] in Serum or Plasma
6201
51863
1.39
66.99
4.2
3.8
mmol/l
6.5
6.3
13.49
5500
46894
(3034274) Bile acid [Moles/volume] in Serum --fasting
638
3121
2.10
63.82
2.3
2.1
umol/l
4.5
5.2
1.74
455
2241
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
3153
23686
1.44
62.35
2.0
1.7
mg/l
1.1
0.9
5.95
2453
17476
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
4929
40385
1.36
57.07
3.8
3.3
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
460
2099
2.23
54.84
1.7
1.6
mmol/l
8.0
7.4
5.15
284
1281
(3044889) 12 lead EKG panel
7256
63334
1.35
54.13
3.0
2.8
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
3480
27189
1.39
53.28
4.1
3.5
estimate
0.0
0.0
0.15
1375
10195
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
3566
28173
1.37
50.35
1.8
1.7
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
2930
22495
1.39
49.06
1.7
1.6
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
6107
52461
1.32
48.21
3.7
3.3
estimate
0.0
0.0
0.36
1363
10165
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
11598
110652
1.76
48.08
9.6
8.7
u/l
25.3
23.7
9.43
11416
107444
(3020564) Creatinine [Moles/volume] in Serum or Plasma
11478
109278
1.69
46.86
12.5
11.0
umol/l
66.4
66.3
0.23
11470
109222
(3021601) Nitrite [Presence] in Urine by Test strip
6051
52044
1.31
46.73
4.9
4.4
estimate
0.0
0.0
0.10
1389
10246
(3017817) Protein [Mass] in Urine collected for unspecified duration
156
443
3.55
46.06
3.4
2.3
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
6012
51775
1.31
45.48
3.7
3.2
estimate
0.0
0.0
1.56
1350
9981
(3026008) Bacteria identified in Urine by Culture
3631
29301
1.34
43.09
2.7
2.5
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
9493
87479
1.36
42.58
5.2
4.2
mmol/mol
39.0
37.4
53.36
9080
82525
(3050129) First trimester maternal screen panel - Serum or Plasma
1423
9789
1.51
42.28
1.5
1.4
—
—
—
0
0
(4034850)
553
3015
1.87
40.29
7.8
7.2
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
2782
21903
1.35
38.11
4.0
3.5
kg/l
1.0
1.0
2.11
471
3373
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
5777
50406
1.27
35.80
4.3
3.7
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
7727
69981
1.27
34.42
4.4
3.9
e6/l
1590.2
1835.9
0.14
108
732
(3037467) Urinalysis macro (dipstick) panel - Urine
7970
72518
1.27
33.83
4.4
4.0
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
3448
28470
1.29
32.53
2.7
2.6
ng/l
44.0
54.1
0.15
1547
12826
(3015736) pH of Urine
4615
39748
1.25
30.06
3.4
3.0
—
6.0
—
0
15
(3008152) Bicarbonate [Moles/volume] in Arterial blood
597
3623
1.68
30.02
6.8
6.5
mmol/l
24.3
24.5
0.57
557
3357
(3032080) INR in Blood by Coagulation assay
3453
28769
1.27
29.74
5.7
5.3
inr
1.1
1.1
1.57
1219
9368
(3041096) Erythrocytes [Presence] in Urine by Automated
3582
29988
1.27
29.63
3.1
2.8
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
1451
10708
1.40
29.02
2.4
2.1
u/l
7337.1
5695.3
1.16
696
4312
(3024561) Albumin [Mass/volume] in Serum or Plasma
4276
36632
1.25
28.84
4.5
4.2
g/l
36.1
36.7
9.75
4035
34124
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
504
2974
1.72
28.12
2.7
2.4
g/l
3.9
3.5
7.94
458
2808
(3019060) Gas panel - Arterial blood
590
3652
1.64
27.47
4.7
4.7
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
254
1223
2.09
26.54
2.4
2.4
ug/min
99.1
49.8
0.97
159
754
(3018677) aPTT in Platelet poor plasma by Coagulation assay
1484
11147
1.37
26.51
1.9
2.0
s
29.1
29.2
0.38
1418
10787
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
10695
102153
1.33
25.08
4.3
3.8
mmol/l
2.9
2.9
6.69
10205
96326
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
10219
97005
1.30
25.00
4.0
3.6
mmol/l
5.8
5.6
35.40
9697
90928
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
10640
101598
1.33
24.64
5.5
5.0
mu/l
1.9
2.0
0.17
10198
96232
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
376
2125
1.79
24.42
1.6
1.5
mmol/l
7.0
6.7
0.77
263
1535
(40761511) CBC panel - Blood by Automated count
11582
112277
1.48
23.17
11.6
9.7
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
834
5798
1.47
22.98
6.0
7.3
%
96.4
96.2
0.25
797
5557
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
257
1324
1.96
22.33
1.6
1.4
mmol/l
11.3
10.7
0.20
27
180
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
10526
100609
1.30
22.32
3.8
3.5
mmol/l
1.5
1.6
130.74
10099
95324
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
9569
90457
1.25
22.01
4.8
4.4
pmol/l
14.5
14.3
10.28
9111
84874
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
5269
47065
1.20
21.61
5.1
5.4
umol/l
9.6
9.6
0.05
4983
44337
(3020891) Body temperature
385
2284
1.70
21.12
5.1
4.3
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
10561
101170
1.29
20.69
3.9
3.6
mmol/l
4.8
4.9
29.23
10150
96039
(3037121) Protein [Mass/volume] in Urine
413
2537
1.65
19.86
2.7
2.9
g/l
0.3
0.2
1.40
208
911
(3002173) Hemoglobin [Mass/volume] in Arterial blood
784
5540
1.44
19.79
6.3
7.5
g/l
121.2
120.3
0.58
752
5330
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
3378
29105
1.22
19.67
2.5
2.4
u/l
53.4
57.1
1.94
3176
26932
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
250
1334
1.89
19.61
1.2
1.2
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
1224
9354
1.34
19.23
3.6
3.3
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
140
607
2.32
19.09
1.5
1.4
nmol/l
1.7
1.5
1.58
125
546
(3027801) Oxygen [Partial pressure] in Arterial blood
921
6754
1.39
18.81
6.0
6.7
kpa
12.9
13.6
3.95
874
6449
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
921
6757
1.39
18.76
6.0
6.7
kpa
5.0
5.1
1.28
873
6458
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
7893
73666
1.19
18.38
6.7
6.7
u/l
74.9
72.6
3.61
7506
69546
(3003396) Base excess in Arterial blood by calculation
920
6775
1.38
18.31
6.0
6.7
mmol/l
1.1
0.9
0.68
690
5212
(3007853) Bacteria identified in Skin by Aerobe culture
1411
11084
1.31
18.20
1.7
1.6
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
298
1726
1.74
17.88
4.5
4.1
mmol/l
3.8
3.8
1.59
286
1620
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
927
6888
1.37
17.45
2.8
2.3
ml/min/173m2
69.9
76.4
4.71
345
2572
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
3535
30922
1.20
17.02
1.7
1.7
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
10097
96669
1.23
16.98
3.5
3.2
mmol/l
1.3
1.2
37.67
9682
91292
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
1919
15813
1.25
16.68
2.5
2.4
ng/l
778.5
653.4
0.85
1607
12937
(3047181) Lactate [Moles/volume] in Blood
350
2181
1.62
15.96
4.6
5.0
mmol/l
1.3
1.2
0.52
307
1936
(3044640) Blood type and Crossmatch panel - Blood
3642
32111
1.19
15.77
2.0
2.0
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
3766
33366
1.18
15.29
2.0
2.0
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
2811
24283
1.20
15.20
1.7
1.6
mmol/l
1.4
1.3
8.73
2403
21129
(3011985) Renin [Units/volume] in Plasma
222
1246
1.79
14.92
1.6
1.8
mu/l
42.7
50.0
0.56
202
1142
(3000850) Epithelial cells [#/volume] in Urine
2121
17861
1.22
14.89
2.5
2.3
e6/l
8.5
8.5
0.04
1841
15418
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
1705
14031
1.25
14.86
3.0
2.9
ng/l
240.8
278.3
0.24
951
7672
(3014576) Chloride [Moles/volume] in Serum or Plasma
1018
7865
1.32
14.72
6.2
6.3
mmol/l
104.5
104.8
1.54
1002
7725
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
252
1492
1.70
14.07
1.2
1.1
iu/ml
61.2
7250.8
0.64
81
371
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
2157
18321
1.21
13.78
1.7
1.6
pmol/l
68146644.7
34176371.1
1.33
1915
15824
(3003694) ABO and Rh group [Type] in Blood
3935
35224
1.17
13.70
1.9
1.7
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
394
2618
1.52
13.63
3.0
3.0
mmol/l
25.2
25.4
0.41
377
2526
(3023368) Bacteria identified in Blood by Culture
2165
18425
1.21
13.52
3.5
3.7
—
—
—
0
0
(40761535) Cells panel - Urine sediment
853
6518
1.33
13.32
3.8
3.2
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
366
2408
1.53
13.26
4.5
4.6
%
1.7
1.8
0.38
340
2243
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
387
2581
1.51
13.17
4.2
2.8
%
0.7
0.7
0.51
366
2475
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
3821
34236
1.16
12.97
3.0
3.0
u/l
30.4
29.1
0.57
3649
32686
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
202
1153
1.76
12.89
1.4
1.4
pmol/l
324.1
355.7
0.44
172
902
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
392
2639
1.50
12.76
4.2
2.8
%
1.3
1.4
0.58
392
2615
(3007930) Methemoglobin/Hemoglobin.total in Blood
360
2383
1.52
12.70
4.6
4.7
%
0.9
0.9
0.06
334
2226
(3004119) Hemoglobin [Mass/volume] in Venous blood
491
3458
1.43
12.67
4.2
3.0
g/l
127.7
129.7
1.20
479
3368
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
165
895
1.85
12.48
1.4
1.5
mmol/l
5.4
5.3
0.55
158
853
(3020876) Protein [Mass/time] in 24 hour Urine
100
457
2.19
12.20
2.9
1.7
g/24h
1.5
0.9
0.66
11
28
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
10917
106051
1.24
12.19
11.5
10.4
mg/l
18.8
18.7
0.03
8918
80842
(3039000) Anion gap in Blood
231
1395
1.66
12.04
5.6
6.3
mmol/l
11.4
11.0
1.26
206
1252
(3018572) Chloride [Moles/volume] in Blood
231
1396
1.66
12.01
5.6
6.3
mmol/l
105.6
105.6
0.08
206
1253
(3002385) Erythrocyte distribution width [Ratio]
9597
92211
1.17
11.74
13.7
12.6
%
13.5
13.5
1.43
9429
90541
(3002582) Erythrocytes [#/volume] in Urine
2915
25756
1.17
11.59
2.9
2.7
e6/l
72.9
72.8
0.00
2185
19081
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
1066
8550
1.27
11.50
1.5
1.5
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
4569
41785
1.14
11.24
2.5
2.2
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
1128
9133
1.26
11.22
4.9
4.8
mmol/l
1.1
1.0
1.32
1085
8542
(3016244) Insulin [Units/volume] in Serum or Plasma
168
953
1.77
11.03
4.1
3.3
mu/l
31.5
28.4
0.40
161
909
(3021447) Carbon dioxide [Partial pressure] in Venous blood
699
5345
1.32
10.88
4.1
3.5
kpa
5.8
5.8
0.73
675
5184
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
235
1471
1.61
10.67
2.4
2.5
nmol/l
0.9
0.8
1.67
203
1250
(3002032) Base excess in Venous blood by calculation
691
5310
1.32
10.39
4.1
3.5
mmol/l
1.8
1.9
0.14
552
4349
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
16
733
0.22
10.35
8.8
12.1
nmol/l
713.1
842.7
0.81
16
708
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
596
4492
1.34
10.26
2.4
2.4
ng/l
109.3
113.2
0.11
531
4044
(3012095) Magnesium [Moles/volume] in Serum or Plasma
1507
12717
1.21
10.07
2.9
3.1
mmol/l
0.8
0.8
3.11
1439
11857
(3036489) Thrombin time
518
3857
1.35
9.68
1.8
1.9
s
21.0
20.7
0.47
410
3202
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
9910
95817
1.16
9.68
9.5
9.0
ml/min/173m2
91.1
90.4
2.40
8311
77906
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
4558
41992
1.13
9.54
5.8
5.4
mmol/l
1.2
1.2
4.58
3867
35514
(3007461) Platelets [#/volume] in Blood
12076
119221
1.50
9.53
17.8
15.7
e9/l
269.3
268.8
0.39
11935
116960
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
573
4342
1.33
9.53
2.0
2.0
ug/l
5.3
5.8
0.33
525
3747
(3035941) MCH [Entitic mass]
12083
119316
1.50
9.39
17.7
15.6
pg
29.8
30.0
34.11
12025
118216
(3011397) Hemoglobin [Presence] in Urine by Test strip
2644
23512
1.16
9.36
3.9
3.2
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
2686
23917
1.15
9.33
2.3
2.1
mg/l
2.9
2.7
5.26
2404
20544
(3024731) MCV [Entitic volume]
12083
119326
1.50
9.27
17.7
15.6
fl
89.7
90.3
59.80
12025
118226
(3026361) Erythrocytes [#/volume] in Blood
12083
119336
1.49
9.15
17.8
15.6
e12/l
4.5
4.4
32.48
11918
116926
(3021589) Normoblasts [#/volume] in Blood
4895
45379
1.13
9.12
8.4
8.0
e9/l
0.0
0.0
0.07
4144
37170
(3010813) Leukocytes [#/volume] in Blood
12084
119364
1.49
8.96
17.8
15.7
e9/l
7.0
6.6
66.46
11921
116892
(3000963) Hemoglobin [Mass/volume] in Blood
12085
119378
1.49
8.94
17.9
15.7
g/l
133.3
132.9
2.98
12027
118285
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
481
3596
1.35
8.79
6.8
8.6
%
1.4
1.4
0.14
481
3570
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
433
3192
1.37
8.66
7.0
8.7
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2664
23848
1.15
8.47
2.0
2.0
u/l
126.6
140.6
1.23
2529
22517
(3026782) Osmolality of Urine
1871
16326
1.17
8.43
2.6
2.4
mosm/kgh2o
523.6
517.4
0.54
1593
13813
(3024354) Oxygen [Partial pressure] in Venous blood
558
4292
1.31
8.39
3.9
2.9
kpa
4.7
4.7
0.11
542
4153
(3018418) pH of Serum or Plasma
2797
25171
1.14
8.19
3.8
3.5
ph
7.4
7.4
0.26
572
4747
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
277
1910
1.46
8.15
3.2
2.8
mg/l
1.5
1.3
2.88
259
1796
(3030467) Casts [#/volume] in Urine by Automated count
2622
23528
1.14
7.99
2.9
2.7
e6/l
0.3
0.3
0.23
1952
17087
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
446
3347
1.34
7.98
2.0
2.0
%
93.8
95.8
1.03
400
3049
(40760892) CBC W Ordered Manual Differential panel - Blood
2871
25928
1.14
7.93
4.0
3.9
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
125
722
1.73
7.85
1.2
1.2
u/ml
41.3
12.1
—
10
81
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
1375
11784
1.18
7.68
1.7
1.7
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
936
7751
1.22
7.56
1.5
1.6
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
589
4629
1.28
7.55
1.6
1.5
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
9999
102208
0.87
7.55
12.3
11.3
%
39.5
39.5
0.59
7861
83075
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
2400
21486
1.14
7.52
1.3
1.3
u/ml
7.6
9.9
1.43
1079
9064
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
881
10584
0.82
7.48
3.5
3.6
%
31.4
33.0
5.03
712
7730
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
951
7900
1.22
7.45
2.6
2.7
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
6126
57979
1.11
7.20
3.2
2.9
ug/l
71.3
70.3
0.23
5850
55020
(3004775) Volume in Urine collected for unspecified duration
76
388
1.96
7.11
2.4
2.2
ml
650.9
617.5
0.35
61
306
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
258
1806
1.43
7.07
2.7
2.2
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
458
3517
1.31
7.03
1.2
1.2
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
900
7485
1.22
6.98
16.2
13.4
inr
1.1
1.1
0.05
154
1253
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
915
7642
1.21
6.80
1.5
1.6
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
290
2091
1.39
6.74
1.5
1.5
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
962
8086
1.20
6.68
1.5
1.4
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
47
204
2.30
6.68
1.5
1.4
—
—
—
0
0
(3022621) pH of Urine by Test strip
783
6459
1.22
6.60
2.9
2.6
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
963
8111
1.20
6.55
1.5
1.4
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
87
478
1.82
6.54
1.1
1.2
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
806
6678
1.22
6.50
3.1
3.1
mmol/l
1.2
1.2
0.02
702
5834
(3016750) Collection duration of Urine
62
305
2.03
6.47
2.1
2.1
min
510.7
503.8
0.30
53
256
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
165
1077
1.54
6.44
2.2
1.6
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
963
8135
1.20
6.34
1.5
1.4
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
2615
23766
1.12
6.33
2.0
1.9
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
475
3721
1.28
6.31
2.0
1.9
g/l
0.2
0.2
0.33
458
3528
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
963
8140
1.20
6.30
1.5
1.4
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
89
501
1.78
6.20
1.2
1.2
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
1193
10296
1.17
6.12
2.0
2.0
nmol/l
362.8
377.9
2.05
1118
9500
(3048929) Epstein Barr virus Ab [Presence] in Serum
518
4123
1.26
6.06
1.2
1.2
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
485
3830
1.27
6.05
2.0
1.9
g/l
1.2
1.2
4.16
468
3642
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
186
1263
1.48
6.04
1.2
1.3
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
625
5089
1.24
5.99
6.9
6.7
mmol/l
7.9
7.3
1.68
615
4885
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
141
905
1.56
5.97
1.3
1.3
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
301
2232
1.35
5.94
1.3
1.2
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
4022
37527
1.10
5.90
5.2
4.7
mmol/l
1.2
1.2
8.13
3746
34186
(3014111) Lactate [Moles/volume] in Serum or Plasma
665
5490
1.22
5.60
6.2
6.3
mmol/l
1.3
1.2
0.94
637
5305
(3000991) Gas panel - Venous blood
616
5048
1.23
5.58
7.2
7.7
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
1223
10663
1.16
5.51
2.4
2.4
umol/l
5.7
6.2
0.59
1038
8902
(36304419) Bacteria [Presence] in Urine
2584
23639
1.11
5.49
2.8
2.6
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
102
621
1.64
5.41
3.3
2.6
mg/l
77.8
33.7
1.42
84
412
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
407
3196
1.28
5.36
2.3
2.2
%
175.5
167.1
1.26
375
3009
(3042936) Bacteria identified in Isolate by Culture
1344
11831
1.15
5.31
1.9
1.8
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
85
496
1.71
5.30
1.2
1.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
489
3944
1.25
5.16
2.6
2.8
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
153
1037
1.48
5.09
1.3
1.4
—
—
—
0
0
(3012565) Volume of 24 hour Urine
71
399
1.78
5.06
2.0
1.9
ml
1898.8
2014.0
0.44
64
374
(40768793) Breast Pathology biopsy report
278
3642
0.76
5.02
1.3
1.3
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
137
919
1.49
4.82
1.2
1.1
ratio
1.0
1.1
1.33
44
350
(3003338) MCHC [Mass/volume]
9742
95110
1.10
4.76
15.1
13.1
g/l
332.0
331.7
3.46
9677
94460
(3030981) Hyaline casts [#/volume] in Urine by Automated count
491
4001
1.23
4.74
2.6
2.3
e6/l
0.3
0.2
0.39
470
3834
(3020630) Protein [Mass/volume] in Serum or Plasma
609
5073
1.21
4.73
2.6
2.3
g/l
66.8
67.2
0.72
576
4658
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
290
2224
1.31
4.64
1.4
1.3
u/ml
17.2
18.9
—
8
42
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
2445
22485
1.11
4.63
1.3
1.3
iu/ml
40.5
29.5
0.39
797
7039
(3015171) Extractable nuclear Ab [Units/volume] in Serum
646
5427
1.20
4.60
1.3
1.3
u/ml
0.5
1.1
1.70
77
435
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
124
825
1.50
4.56
1.3
1.3
—
—
—
0
0
(3019225) pH of Specimen
684
8021
0.84
4.53
3.5
3.5
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
33
147
2.24
4.52
1.4
1.4
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
3516
32936
1.09
4.48
3.5
3.2
e6/l
84.4
77.0
0.33
2395
21251
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
290
2242
1.30
4.39
1.4
1.3
—
—
—
0
0
(44790049)
129
875
1.48
4.34
1.3
1.5
—
—
—
0
0
(44806118)
129
875
1.48
4.34
1.3
1.5
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
326
4101
0.79
4.34
1.3
1.3
ug/l
4.4
3.1
0.96
294
3739
(44790047)
129
876
1.47
4.32
1.3
1.5
—
—
—
0
0
(44790048)
129
876
1.47
4.32
1.3
1.5
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
112
739
1.52
4.31
4.0
3.1
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
265
2030
1.31
4.30
1.9
2.0
ug/l
1.4
2.0
0.74
231
1808
(3037522) Nuclear Ab [Titer] in Serum
1892
17245
1.11
4.23
1.4
1.4
titre
556.9
565.1
0.06
408
3532
(4035726)
683
7960
0.85
4.22
1.3
1.4
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
7954
77113
1.08
4.19
4.0
3.8
mm/h
11.0
10.0
13.22
7573
72505
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
1301
11613
1.13
4.18
1.3
1.2
iu/ml
159.1
152.7
0.18
549
4552
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
99
642
1.54
4.14
1.0
1.1
%
93.4
92.6
0.13
79
515
(3015235) Bicarbonate [Moles/volume] in Capillary blood
200
1484
1.35
4.07
2.6
2.6
mmol/l
24.5
24.5
0.00
177
1313
(3004789) Transferrin [Mass/volume] in Serum or Plasma
1375
12339
1.13
4.05
2.3
2.1
g/l
2.5
2.5
1.52
1283
11436
(3022948) Iron [Moles/volume] in Serum or Plasma
1520
13734
1.12
3.99
2.3
2.2
umol/l
13.5
14.4
5.11
1439
12755
(40767503) Oxygen content in Capillary blood by calculation
191
1413
1.35
3.97
2.2
2.1
%
16.5
16.8
0.53
87
672
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
361
4439
0.81
3.96
1.4
1.4
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
119
811
1.47
3.95
1.1
1.0
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
1055
9331
1.14
3.92
3.4
3.4
pmol/l
4.5
4.5
0.04
968
8391
(3020491) Glucose [Moles/volume] in Blood
116
788
1.47
3.92
1.9
1.6
mmol/l
5.7
6.0
0.62
94
618
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
268
2085
1.29
3.91
1.4
1.3
u/ml
103.5
109.1
0.52
69
476
(3005322) IgE [Units/volume] in Serum or Plasma
982
8646
1.14
3.91
1.3
1.3
u/ml
163.1
185.9
0.32
921
8009
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
119
816
1.46
3.84
1.2
1.2
u/l
36.5
28.3
0.29
109
715
(3025130) Human papilloma virus identified in Specimen
276
3470
0.79
3.71
1.7
1.8
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
170
1261
1.35
3.52
1.3
1.4
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
40
718
0.55
3.52
1.7
1.5
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
111
772
1.44
3.38
3.6
3.7
mmol/l
7.0
7.0
0.04
86
623
(3006653) Thiamine [Moles/volume] in Blood
78
505
1.54
3.36
1.8
1.4
nmol/l
135.1
131.1
0.39
78
505
(4062490)
153
1126
1.36
3.36
1.6
1.4
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
269
2140
1.26
3.34
1.5
1.6
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
1892
17452
1.10
3.32
1.5
1.4
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
9128
89263
1.08
3.32
4.0
3.7
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
84
555
1.51
3.31
1.2
1.3
%
72.3
66.8
—
10
66
(3027923) C peptide [Moles/volume] in Serum or Plasma
66
413
1.60
3.30
2.7
2.0
nmol/l
1.6
1.3
1.18
57
338
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
301
2433
1.24
3.26
1.3
1.3
e6/l
11.7
32.5
1.90
236
1872
(3017181) Myelocytes/100 leukocytes in Blood
867
7673
1.14
3.24
3.9
4.0
%
0.9
0.9
0.26
174
1731
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
1221
11032
1.12
3.23
2.4
2.2
%
22.5
23.7
2.24
1051
9537
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
301
2437
1.24
3.22
1.3
1.4
e6/l
2697.3
2497.3
0.03
248
1968
(4211845)
85
568
1.50
3.19
2.3
2.7
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
25
117
2.13
3.13
1.2
1.2
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
181
2341
0.77
3.12
3.9
3.7
u/ml
28.3
30.6
0.15
175
2250
(3006184) Hemoglobin [Mass/volume] in Capillary blood
204
1593
1.28
2.99
2.2
1.9
g/l
128.8
130.8
0.56
165
1158
(3028192) IgG subclass 2 [Mass/volume] in Serum
150
1124
1.34
2.97
1.6
1.4
g/l
3.2
3.0
0.60
108
788
(3024139) IgG subclass 3 [Mass/volume] in Serum
150
1125
1.33
2.96
1.6
1.4
g/l
0.5
0.4
0.43
108
795
(3027135) IgG subclass 1 [Mass/volume] in Serum
150
1125
1.33
2.96
1.6
1.4
g/l
6.5
6.6
0.14
108
792
(1761482) Bacteria [#/volume] in Urine by Culture
200
1561
1.28
2.95
2.8
3.5
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
797
7063
1.13
2.94
4.0
4.1
%
0.0
0.3
1.68
131
1369
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
659
7479
0.87
2.94
1.1
1.1
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
830
9274
0.89
2.91
1.3
1.3
—
—
—
0
0
(3012501) Base excess in Blood by calculation
203
1592
1.28
2.89
2.6
2.8
mmol/l
2.4
2.3
0.09
126
990
(1617658) Protocol used for examination of sentinel lymph nodes
77
1123
0.68
2.87
1.0
1.0
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
73
486
1.50
2.83
1.8
2.1
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
828
7377
1.13
2.82
4.0
4.0
%
0.1
0.2
1.45
158
1608
(3006598) pH of Arterial cord blood
10
31
3.22
2.76
1.0
1.1
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
140
1052
1.33
2.75
2.7
2.4
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
2452
23041
1.08
2.75
3.3
3.3
%
99.5
98.0
2.50
2356
22329
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
1513
13938
1.09
2.74
2.5
2.3
e6/l
1.3
1.4
0.12
845
7402
(3023511) Choriogonadotropin [Units/volume] in Urine
647
5691
1.14
2.70
1.4
1.3
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
665
7494
0.88
2.69
3.3
3.7
ug/l
4.5
21.6
2.41
484
5478
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
163
1257
1.30
2.67
1.7
1.4
—
—
—
0
0
(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma
8
19
4.20
2.67
2.5
2.0
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
97
1334
0.72
2.62
4.3
5.6
umol/l
339.4
380.1
2.26
86
1159
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
67
447
1.50
2.60
1.1
1.1
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
262
2146
1.22
2.59
1.3
1.2
u/ml
270.2
261.8
0.21
176
1428
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
20
93
2.15
2.58
13.3
8.7
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
849
7622
1.12
2.56
2.6
2.6
g/l
10.8
10.4
1.97
789
6976
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
35
200
1.75
2.53
1.3
1.2
pmol/l
328.5
397.0
0.34
27
156
(3006462) Nitrate [Presence] in Urine
75
517
1.45
2.49
2.3
2.8
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
19
88
2.16
2.49
13.6
8.7
—
—
—
0
0
(3008898) HLA-B27 [Presence]
658
5833
1.13
2.47
1.1
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
39
233
1.67
2.42
1.1
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
39
233
1.67
2.42
1.1
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
39
233
1.67
2.42
1.1
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
39
233
1.67
2.42
1.1
1.1
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
211
1704
1.24
2.41
2.6
2.6
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
28
152
1.84
2.40
5.4
5.9
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
1221
13220
0.91
2.39
1.5
1.5
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
3108
29578
1.06
2.39
1.3
1.3
u/ml
1.8
1.5
0.61
1029
8467
(21494755) Public health laboratory ask at order entry panel
1456
15640
0.92
2.38
1.3
1.3
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
652
5795
1.13
2.36
1.5
1.6
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
14
58
2.41
2.35
1.3
1.2
—
—
—
0
0
(3015147) Influenza virus A IgG Ab [Units/volume] in Serum
7
17
4.11
2.35
1.1
1.0
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
166
1308
1.27
2.35
2.9
2.3
kpa
8.8
8.7
0.33
155
1224
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
464
4035
1.15
2.33
2.0
2.0
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
29
161
1.80
2.32
1.8
1.4
ng/l
91.0
78.9
0.32
29
161
(3034770) Mitochondria Ab [Titer] in Serum
332
2814
1.18
2.31
1.2
1.3
titre
1440.0
807.5
—
8
114
(3002179) Metamyelocytes/100 leukocytes in Blood
786
7072
1.12
2.31
3.7
3.8
%
0.6
0.6
0.02
120
1269
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
419
3620
1.16
2.30
2.6
2.8
mmol/l
1.6
1.5
0.25
288
2581
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
274
2287
1.20
2.28
1.2
1.2
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
4514
46615
0.95
2.27
2.0
2.0
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
71
496
1.43
2.23
1.2
1.2
—
—
—
0
0
(3009343) pH of Capillary blood
431
3744
1.15
2.21
2.7
2.8
ph
7.4
7.4
0.16
50
517
(3023520) Reticulocytes [#/volume] in Blood
555
4906
1.13
2.21
2.6
2.5
e9/l
77.3
71.1
2.90
426
3530
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
227
1869
1.22
2.19
1.3
1.4
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
286
2407
1.19
2.18
1.9
1.8
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
40
249
1.60
2.15
2.0
2.1
ug/min
22.6
79.9
—
8
47
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
32
188
1.70
2.14
1.0
1.1
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
205
1675
1.22
2.14
1.3
1.6
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
50
330
1.51
2.10
1.2
1.1
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
210
1724
1.22
2.10
1.3
1.5
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
434
3794
1.15
2.06
2.7
2.8
kpa
5.1
5.1
0.12
407
3530
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
231
1919
1.20
2.05
1.1
1.1
%
123.4
120.5
0.93
205
1743
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
93
694
1.34
2.01
1.5
1.6
%
37.8
39.2
0.13
64
405
(3044242) Glucose [Moles/volume] in Arterial blood
40
254
1.57
2.01
2.3
1.9
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
337
2899
1.16
2.01
5.2
4.0
mmol/l
24.3
24.3
0.03
277
2626
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
187
1526
1.23
2.00
1.3
1.3
—
—
—
0
0
(3010421) pH of Blood
225
1871
1.20
1.99
2.5
2.7
ph
7.4
7.4
1.50
200
1563
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
21
111
1.89
1.99
1.2
1.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
581
6462
0.89
1.97
1.8
2.0
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
647
5821
1.12
1.95
1.7
1.8
g/l
1.2
1.3
3.31
605
5353
(3007566) Smooth muscle Ab [Titer] in Serum
330
2843
1.16
1.94
1.2
1.3
titre
138.1
152.8
0.11
32
272
(3006922) Hepatitis E virus Ab [Presence] in Serum
97
734
1.32
1.93
1.1
1.1
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
979
10591
0.92
1.92
1.4
1.4
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
120
936
1.28
1.91
1.3
1.4
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
156
1256
1.24
1.90
1.8
1.6
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
809
7375
1.10
1.90
2.1
2.2
g/l
0.2
0.2
0.51
763
6947
(3003327) Ova and parasites identified in Stool by Light microscopy
421
4760
0.88
1.89
1.7
1.7
—
—
—
0
0
(1616796) Gas panel - Central venous blood
188
1549
1.21
1.85
2.9
2.6
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
43
284
1.51
1.84
1.7
1.4
umol/l
17.7
17.7
0.00
36
251
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
333
3812
0.87
1.81
1.4
1.5
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
29
464
0.62
1.80
1.9
2.2
umol/l
124.2
156.4
—
10
233
(3011288) Drugs identified in Urine by Screen method
399
4511
0.88
1.80
2.8
2.8
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
64
877
0.73
1.80
1.3
1.3
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
64
877
0.73
1.80
9.1
12.4
mmol/l
0.6
0.6
0.02
59
812
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
692
7578
0.91
1.78
1.7
1.7
—
—
—
0
0
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
49
336
1.46
1.76
1.2
1.2
%
31.1
18.8
—
7
64
(3017569) Oxygen content in Arterial blood
35
223
1.57
1.76
2.3
2.0
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
3217
30893
1.05
1.76
2.9
3.1
mmol/l
2.3
2.3
0.68
2969
27584
(3010937) Rubella virus Ab [Presence] in Serum
23
131
1.75
1.75
1.2
1.1
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
108
842
1.28
1.75
1.3
1.4
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
33
208
1.58
1.74
1.4
1.4
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
6
18
3.33
1.74
2.0
2.4
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
16
81
1.97
1.73
4.8
4.3
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
204
1708
1.19
1.72
1.5
1.5
g/l
0.6
0.6
0.56
155
1285
(3020961) Endomysium IgA Ab [Titer] in Serum
748
6831
1.10
1.72
1.2
1.1
titre
315.0
187.7
0.36
22
167
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
204
2414
0.84
1.70
3.3
3.4
u/ml
102.5
453.1
1.71
183
2039
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
65
473
1.37
1.70
1.2
1.2
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
5290
51446
1.05
1.69
5.3
5.6
e9/l
0.5
0.5
0.97
4732
45452
(3006315) Basophils [#/volume] in Blood
5307
51620
1.05
1.68
5.4
5.7
e9/l
0.0
0.0
1.93
4736
45505
(3019420) Tryptase [Mass/volume] in Serum or Plasma
95
734
1.29
1.67
1.4
1.4
ug/l
6.3
7.0
0.28
85
661
(3027008) Opiates [Presence] in Urine
591
6491
0.90
1.64
1.8
2.0
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
593
6509
0.90
1.63
1.8
2.0
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
388
4359
0.88
1.62
1.3
1.4
pmol/l
63.7
101.5
5.96
376
4248
(3027944) Amphetamines [Presence] in Urine
583
6401
0.90
1.61
1.7
1.9
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
216
1831
1.18
1.61
3.7
3.1
mg/l
21.1
23.7
0.52
137
1093
(3041354) Potassium [Moles/volume] in Venous blood
77
582
1.32
1.60
2.0
1.9
mmol/l
3.9
3.9
0.03
77
576
(3035285) Chloride [Moles/volume] in Venous blood
77
582
1.32
1.60
2.0
1.9
mmol/l
105.2
105.9
0.65
77
576
(3005570) Glucose [Moles/volume] in Urine
117
934
1.25
1.59
1.9
1.9
—
0.8
—
0
6
(3022670) pH of Venous cord blood
8
32
2.50
1.59
1.1
1.1
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
7
26
2.69
1.57
14.6
14.9
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
390
3459
1.13
1.57
1.5
1.5
u/ml
9.3
9.8
—
6
90
(3004716) Salmonella sp identified in Stool by Organism specific culture
699
7594
0.91
1.56
1.5
1.4
—
—
—
0
0
(3004451) EKG impression Narrative
34
223
1.52
1.54
1.2
1.2
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
63
465
1.35
1.54
1.5
1.6
u/field
1.1
1.9
1.53
47
337
(4027681)
119
957
1.24
1.53
1.2
1.2
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
23
137
1.68
1.53
1.1
1.1
—
—
—
0
0
(3024263) Appearance of Synovial fluid
49
347
1.41
1.53
1.8
2.0
—
—
—
0
0
(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count
0
43
0.00
1.52
0.0
1.4
—
16.1
—
0
17
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
6
140
0.43
1.51
2.0
1.5
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
67
501
1.34
1.51
1.3
1.2
%
108.8
110.3
0.18
62
451
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
79
607
1.30
1.48
1.7
1.9
u/field
1.7
2.4
0.69
43
307
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
12
58
2.07
1.48
13.5
6.2
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
1413
13323
1.07
1.48
1.8
1.7
nmol/l
1285.6
1178.3
4.66
1203
10350
(3013512) EKG study
2284
21840
1.05
1.47
2.9
2.9
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
29
186
1.56
1.46
1.1
1.1
umol/24h
0.6
0.6
0.24
16
90
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
72
935
0.77
1.46
1.3
1.8
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
261
2984
0.87
1.45
1.3
1.3
—
—
—
0
0
(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma
16
87
1.84
1.44
1.9
3.4
mmol/l
1.3
1.0
0.21
11
65
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
32
211
1.51
1.44
1.4
1.6
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
65
489
1.33
1.42
3.0
2.9
mg/l
7.8
8.3
0.25
49
384
(4306422)
235
2030
1.16
1.42
1.1
1.2
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
540
5907
0.91
1.42
1.8
2.1
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
1302
13752
0.94
1.41
1.6
1.6
%
1.3
1.3
0.29
1167
12414
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
278
2433
1.14
1.40
1.2
1.2
mmol/l
3.6
3.6
0.30
263
2282
(3013650) Neutrophils [#/volume] in Blood by Automated count
6047
59134
1.04
1.40
7.6
8.5
e9/l
4.1
3.9
11.33
5394
52187
(3027945) Reticulocytes/100 erythrocytes in Blood
765
7069
1.09
1.40
2.6
2.4
%
1.9
1.7
2.13
698
6277
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
102
816
1.25
1.40
6.1
6.5
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
154
1286
1.20
1.40
1.1
1.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
536
4877
1.10
1.39
2.2
2.0
—
—
—
0
0
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
60
448
1.34
1.39
2.4
2.4
au/ml
117.9
149.4
—
8
68
(3015183) Erythrocyte sedimentation rate
99
791
1.25
1.38
1.2
1.2
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
1724
16396
1.06
1.36
1.6
1.6
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
5467
53378
1.04
1.36
5.3
5.6
e9/l
2.0
2.0
0.32
5006
48055
(3051593) INR in Capillary blood by Coagulation assay
10
197
0.51
1.36
8.1
6.0
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
72
554
1.30
1.36
3.9
3.0
nmol/l
0.8
0.8
0.10
56
415
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
16
89
1.79
1.36
1.1
1.1
umol/24h
1.4
1.5
0.41
16
89
(3003531) Amoxicillin IgE Ab [Units/volume] in Serum
5
17
2.94
1.35
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
84
660
1.27
1.35
1.1
1.1
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
84
660
1.27
1.35
1.3
1.2
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
57
754
0.75
1.35
2.6
3.0
—
—
—
0
0
(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma
0
37
0.00
1.34
0.0
1.2
—
131.8
—
0
22
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
75
582
1.29
1.33
1.8
1.6
nmol/l
5.8
11.8
0.27
58
474
(3037556) Urate [Mass/volume] in Serum or Plasma
27
175
1.54
1.32
1.5
1.2
—
—
—
0
0
(3003157) Bacteria [#/volume] in Mother's milk
11
54
2.03
1.32
6.4
7.1
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
313
2775
1.13
1.32
1.2
1.3
mg/l
440.2
448.6
0.10
298
2650
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
23
356
0.64
1.31
2.8
5.4
—
1560.7
—
0
55
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
394
3541
1.11
1.31
1.6
1.6
iu/ml
0.6
5.2
0.47
73
680
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
77
602
1.28
1.30
1.3
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
77
602
1.28
1.30
1.3
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
77
602
1.28
1.30
1.3
1.6
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
46
624
0.73
1.30
1.1
1.1
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
20
318
0.63
1.29
1.1
1.1
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
6
131
0.46
1.28
1.0
1.0
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
80
1004
0.79
1.27
2.1
1.9
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
97
782
1.24
1.27
2.2
2.6
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
84
667
1.26
1.26
1.1
1.1
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
515
4705
1.10
1.25
1.7
1.7
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
28
186
1.50
1.24
1.3
1.3
—
—
—
0
0
(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection
8
36
2.22
1.24
1.8
1.2
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
48
354
1.35
1.23
2.0
2.0
e6/l
156.4
188.0
0.37
28
188
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
244
2762
0.88
1.22
1.3
1.2
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
192
1657
1.16
1.22
4.7
5.0
iu/ml
2460.1
759.6
0.56
28
192
(3014051) Protein [Presence] in Urine by Test strip
257
2264
1.14
1.22
1.8
1.9
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
31
212
1.46
1.21
4.5
5.2
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
239
2097
1.14
1.21
1.5
1.3
—
—
—
0
0
(3011648) Oxygen content in Venous blood
67
521
1.28
1.20
3.2
2.3
%
12.0
11.0
1.44
67
521
(3036603) Volume of Urine
73
575
1.27
1.19
1.9
1.6
ml
2048.8
1982.1
0.12
16
96
(3013115) Eosinophils [#/volume] in Blood
5475
53562
1.04
1.18
5.5
5.8
e9/l
0.2
0.2
8.23
5012
48029
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
103
844
1.22
1.18
1.1
1.1
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
129
1081
1.19
1.18
1.2
1.1
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
165
1413
1.17
1.17
4.3
4.3
u/ml
59.2
108.5
1.58
44
457
(3024928) Oxygen saturation in Venous blood
151
1284
1.18
1.17
7.2
3.2
—
—
—
0
0
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
25
165
1.51
1.16
1.0
1.1
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
69
542
1.27
1.15
1.3
1.2
g/l
0.3
0.3
0.14
54
436
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
109
903
1.21
1.13
2.9
2.9
nmol/l
5.4
10.3
0.36
104
868
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
315
2825
1.12
1.13
1.8
1.6
titre
277.9
281.0
0.01
17
126
(3033705) Calcium.ionized [Moles/volume] in Venous blood
72
571
1.26
1.12
2.0
2.0
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
196
1709
1.15
1.11
1.1
1.1
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
869
9213
0.94
1.10
2.4
2.9
u/ml
33.4
38.7
0.49
837
8914
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
13
73
1.78
1.10
4.2
11.2
mmol/l
4.4
4.9
0.56
13
73
(40768446) Kidney Pathology biopsy report
35
251
1.39
1.08
1.9
1.6
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
402
3661
1.10
1.08
2.0
2.1
iu/l
3.3
27.4
1.05
167
1515
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
329
3628
0.90
1.08
1.5
1.5
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
766
8148
0.93
1.08
1.2
1.2
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
460
4989
0.92
1.07
2.0
2.1
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
12
205
0.58
1.06
1.2
1.0
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
82
665
1.23
1.06
1.6
1.6
promille
1.2
1.3
0.22
52
509
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
168
1456
1.15
1.05
1.2
1.3
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
202
1774
1.14
1.04
1.1
1.1
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
22
145
1.51
1.04
1.3
1.1
—
—
—
0
0
(4281824)
124
1453
0.85
1.04
1.1
1.1
—
—
—
0
0
(3006567) Chloride [Moles/time] in 24 hour Urine
5
22
2.27
1.03
1.0
1.1
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
11
190
0.58
1.02
1.5
2.0
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
389
3550
1.10
1.02
1.2
1.2
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
191
1675
1.14
1.02
1.3
1.3
u/ml
42.4
58.5
0.52
17
116
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
627
5839
1.08
1.01
3.9
3.2
ng/l
81.2
75.4
0.93
569
5149
(3022493) Free Hemoglobin [Mass/volume] in Plasma
39
290
1.34
0.99
3.5
3.8
mg/l
4555.7
1968.0
0.24
29
209
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
3587
34929
1.03
0.99
1.5
1.5
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
430
3950
1.09
0.99
1.4
1.4
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
20
131
1.52
0.98
1.1
1.0
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
103
1219
0.84
0.98
1.3
1.5
—
—
—
0
0
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
26
181
1.43
0.97
1.0
1.2
mg/l
0.6
89.0
1.67
17
139
(3046861) Legionella sp Ag [Presence] in Urine
0
31
0.00
0.96
0.0
1.0
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
200
1768
1.13
0.96
1.6
1.7
e6/l
8726.1
8356.9
0.06
162
1295
(3001964) Herpes simplex virus Ag [Presence] in Specimen
24
341
0.70
0.95
1.4
1.4
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
50
634
0.79
0.94
1.2
1.2
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
6
120
0.50
0.93
1.3
1.1
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
51
644
0.79
0.93
1.1
1.1
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
36
268
1.34
0.92
2.3
1.4
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
36
268
1.34
0.92
2.3
1.4
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
13
208
0.62
0.92
1.1
1.2
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
10
55
1.81
0.91
3.3
4.2
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
433
3996
1.08
0.91
2.1
2.1
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
3433
35068
0.97
0.91
1.9
1.8
pmol/l
97.0
100.1
3.86
1899
18233
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
28
201
1.39
0.90
1.2
1.1
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
134
1160
1.15
0.89
1.1
1.1
mg/l
194.7
208.1
0.66
124
1011
(3022475) Manganese [Moles/volume] in Blood
5
104
0.48
0.88
1.4
1.2
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
145
1264
1.15
0.88
1.1
1.1
g/l
1.4
1.5
0.69
135
1143
(3017704) Immunofixation for Urine
34
254
1.34
0.87
2.0
1.6
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
137
1191
1.15
0.86
1.2
1.1
mg/l
34.2
36.7
0.32
118
994
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
98
830
1.18
0.86
1.0
1.1
u/l
1.0
1.0
0.57
42
342
(44813793)
115
988
1.16
0.85
1.1
1.1
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
80
666
1.20
0.85
1.1
1.1
nmol/l
11.7
5.5
—
9
117
(3010144) Erythrocytes [#/volume] in Synovial fluid
80
667
1.20
0.84
1.4
1.5
e6/l
8745.4
52356.6
1.83
54
463
(42870588) Differential panel, method unspecified - Blood
3232
33002
0.97
0.84
5.4
5.8
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
130
1130
1.15
0.83
1.4
1.4
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
59
478
1.23
0.82
2.5
2.7
%
40.9
44.8
0.44
18
183
(3005033) Fetal Nuchal fold Thickness US
712
6722
1.06
0.81
1.5
1.4
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
16
105
1.52
0.80
4.8
6.2
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
278
2534
1.10
0.80
1.2
1.2
u/ml
1.6
15.8
—
6
44
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
96
819
1.17
0.79
2.1
2.0
%
12.5
12.8
0.14
50
430
(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis
17
114
1.49
0.78
4.0
4.5
ug/min
18.9
39.8
1.77
12
69
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
0
26
0.00
0.78
0.0
1.0
—
—
—
0
0
(1175426) CD3 cells/100 lymphocytes in Blood
97
830
1.17
0.78
2.1
2.0
%
75.7
75.6
0.03
90
805
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
26
190
1.37
0.77
1.1
1.2
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
90
766
1.17
0.77
2.2
2.1
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
448
4175
1.07
0.77
1.1
1.1
u/ml
2.2
4.7
2.61
54
670
(3006442) Creatine [Moles/volume] in Serum or Plasma
79
665
1.19
0.77
1.4
1.4
umol/l
63.2
64.6
—
5
51
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
64
528
1.21
0.77
1.1
1.1
%
96.9
96.7
0.01
21
225
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
10
162
0.62
0.77
1.0
1.1
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
347
3740
0.92
0.77
1.4
1.4
nmol/l
0.5
0.5
0.07
272
2978
(3006245) CD3-CD19+ cells/100 cells in Blood
58
474
1.22
0.76
2.3
2.1
%
9.9
8.9
0.34
49
451
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
56
456
1.23
0.76
2.0
2.0
%
30.1
27.9
0.57
50
437
(3012494) Peanut IgE Ab [Units/volume] in Serum
56
457
1.22
0.75
1.1
1.1
u/ml
3.2
1.8
0.29
31
258
(40760888) Immunoglobulin light chains.free panel - Serum
135
1188
1.14
0.75
2.9
3.1
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
77
649
1.18
0.74
1.3
1.5
u/l
7.1
5.1
0.53
62
546
(3051651) Icteric interference index of Serum or Plasma
59
485
1.21
0.74
3.3
3.2
—
—
—
0
0
(3034891) Synovial lining cells/100 cells in Synovial fluid
47
377
1.24
0.74
1.5
1.5
%
5.3
4.3
—
9
77
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
12
184
0.65
0.74
1.0
1.1
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
61
732
0.83
0.74
1.1
1.1
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
175
1567
1.12
0.73
3.0
3.1
mg/l
34.2
75.4
0.58
146
1256
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
107
928
1.15
0.73
1.3
1.6
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
40
315
1.27
0.73
1.4
1.4
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
8
133
0.60
0.73
1.0
2.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
2449
25056
0.97
0.72
2.1
2.1
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
25
184
1.36
0.72
1.3
1.2
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
43
534
0.80
0.72
3.8
4.0
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
727
6897
1.05
0.72
1.6
1.5
—
—
—
0
0
(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
7
39
1.79
0.72
1.1
1.1
%
33.5
36.2
—
7
39
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
138
1220
1.13
0.72
1.1
1.1
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
29
219
1.32
0.72
1.7
1.7
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
41
325
1.26
0.71
1.1
1.1
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
97
1115
0.87
0.71
2.5
2.7
%
1.8
1.3
0.39
73
871
(3047352) Trisomy 18 risk [Likelihood] in Fetus
710
6736
1.05
0.71
1.5
1.4
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
64
761
0.84
0.71
1.3
1.5
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
9
57
1.58
0.71
1.1
1.2
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
351
3765
0.93
0.70
1.3
1.4
u/l
21.7
25.2
1.43
299
3085
(3035320) C reactive protein [Mass/volume] in Body fluid
89
764
1.16
0.70
2.7
2.2
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
10
158
0.63
0.70
1.0
1.1
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
467
4376
1.07
0.70
2.3
2.0
u/l
39.7
39.7
0.01
429
4058
(3049242) von Willebrand panel - Platelet poor plasma
5
26
1.92
0.70
1.6
1.6
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
33
255
1.29
0.70
1.2
1.5
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
62
516
1.20
0.70
1.1
1.1
%
102.1
100.0
0.12
20
221
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
174
1564
1.11
0.69
3.0
3.1
mg/l
88.3
32.4
0.68
145
1257
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
9
143
0.63
0.69
1.1
1.0
—
—
—
0
0
(44806420)
15
101
1.48
0.69
2.2
2.2
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
13
192
0.68
0.68
1.2
1.3
—
—
—
0
0
(3034614) HLA Ag [Interpretation]
5
27
1.85
0.68
1.0
1.1
—
—
—
0
0
(3002256) Pathology report gross observation
1352
13957
0.96
0.68
1.2
1.2
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
5
91
0.55
0.67
1.0
1.0
—
—
—
0
0
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
7
43
1.62
0.66
1.1
1.0
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
43
348
1.23
0.65
1.2
1.2
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
7
44
1.59
0.65
1.0
1.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
219
2001
1.09
0.65
1.1
1.1
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
92
799
1.15
0.64
3.1
2.8
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
91
790
1.15
0.64
1.1
1.1
mg/l
285.3
304.8
1.65
86
694
(3005082) Progesterone [Moles/volume] in Serum or Plasma
152
1679
0.90
0.62
1.4
1.4
nmol/l
28.7
31.7
0.86
136
1545
(3044290) Cell count panel - Cerebral spinal fluid
251
2314
1.08
0.61
1.2
1.3
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
144
1595
0.90
0.61
1.7
2.1
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
6
105
0.57
0.61
1.2
1.1
—
—
—
0
0
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
17
121
1.40
0.61
1.1
1.5
%
55.8
56.0
—
6
68
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
5
30
1.66
0.61
2.0
2.0
—
—
—
0
0
(1002224) Polysomnography panel
532
5037
1.06
0.60
1.1
1.1
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
29
226
1.28
0.60
1.0
1.0
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
60
704
0.85
0.60
1.4
1.4
—
—
—
0
0
(3029612) Listeria sp Ab [Titer] in Serum
8
51
1.57
0.60
1.4
1.4
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
134
1200
1.12
0.60
1.3
1.4
—
—
—
0
0
(21494227) Amikacin free [Mass/volume] in Serum or Plasma
0
21
0.00
0.60
0.0
5.3
—
3.7
—
0
13
(3032057) Clostridioides difficile [Presence] in Stool
10
151
0.66
0.60
2.0
1.8
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
107
1203
0.89
0.60
1.2
1.5
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
262
2424
1.08
0.59
1.6
1.6
—
—
—
0
0
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
60
508
1.18
0.59
1.4
1.7
%
133.6
141.0
0.40
53
469
(3004347) Hepatitis D virus Ab [Presence] in Serum
0
22
0.00
0.59
0.0
1.0
—
—
—
0
0
(40762887) Creatinine [Moles/volume] in Blood
0
22
0.00
0.59
0.0
1.1
—
—
—
0
0
(3022313) Gas panel - Capillary blood
280
2599
1.08
0.59
2.6
3.0
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
107
1201
0.89
0.58
1.2
1.5
—
—
—
0
0
(4198724)
51
605
0.84
0.58
1.3
2.5
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
63
537
1.17
0.58
1.2
1.1
%
121.4
116.7
0.44
52
480
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
10
64
1.56
0.58
1.4
3.2
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
27
210
1.28
0.57
1.9
2.0
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
4939
49919
0.98
0.57
5.3
5.5
%
57.3
56.4
7.12
4672
47055
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
26
331
0.78
0.57
2.6
3.1
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
167
1518
1.10
0.57
3.0
3.1
ratio
1.2
1.9
0.82
21
157
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
1556
15097
1.03
0.57
2.3
2.5
mmol/l
2.4
2.4
0.43
1346
13178
(43055514) Macroprolactin [Presence] in Serum or Plasma
47
560
0.84
0.57
1.4
1.4
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
82
715
1.15
0.57
1.4
1.7
%
126.2
123.2
0.16
75
673
(3025941) Bacteria identified in Stool by Culture
746
7140
1.05
0.56
1.2
1.2
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
109
1218
0.89
0.56
1.2
1.4
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
5
86
0.58
0.56
1.2
1.3
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
82
932
0.88
0.55
1.1
1.2
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
141
1274
1.11
0.55
1.7
1.6
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
8
122
0.65
0.54
1.4
1.1
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
8
124
0.64
0.54
1.0
1.1
—
—
—
0
0
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
19
250
0.76
0.54
1.6
1.7
—
500.2
—
0
5
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
400
3773
1.06
0.54
1.3
1.3
u/ml
37.2
32.9
0.13
29
273
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
52
610
0.85
0.54
1.7
1.6
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
146
1324
1.10
0.54
1.1
1.1
—
21.1
—
0
11
(3042111) Morphology [Interpretation] in Bone marrow Narrative
101
898
1.12
0.53
1.5
1.7
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
5007
50561
0.98
0.53
5.4
5.7
%
29.1
29.8
5.32
4715
47525
(3028707) Methadone [Presence] in Urine by Screen method
260
2779
0.93
0.53
2.2
2.7
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
228
2113
1.08
0.52
1.3
1.2
u/ml
3.1
3.0
0.03
74
704
(3015076) Soybean IgE Ab [Units/volume] in Serum
104
929
1.12
0.51
1.0
1.0
u/ml
0.2
0.3
0.33
14
121
(3025468) Yersinia sp identified in Specimen by Organism specific culture
108
1199
0.90
0.51
1.2
1.5
—
—
—
0
0
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
17
126
1.35
0.51
1.9
2.1
mmol/l
8.0
6.5
—
8
71
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
357
3365
1.06
0.50
1.3
1.3
u/ml
3.2
6.1
0.93
42
369
(4094501)
214
1982
1.08
0.50
1.0
1.1
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
9
65
1.38
0.50
1.0
1.0
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
1012
9777
1.04
0.50
6.2
4.8
—
—
—
0
0
(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded
15
109
1.37
0.50
1.0
1.1
—
—
—
0
0
(4133840)
30
242
1.24
0.50
1.1
1.1
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
1100
11314
0.97
0.49
1.4
1.4
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
417
4378
0.95
0.49
1.2
1.2
u/l
12.6
12.4
0.08
362
3634
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
90
1006
0.89
0.49
2.0
1.9
mg/l
18.9
23.3
0.60
27
267
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
355
3351
1.06
0.48
2.1
2.0
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
110
1215
0.90
0.48
1.2
1.4
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
27
333
0.81
0.48
1.1
1.2
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
51
436
1.17
0.48
1.2
1.2
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
137
1249
1.10
0.47
1.1
1.1
—
—
—
0
0
(3020356) Listeria sp identified in Specimen by Organism specific culture
21
163
1.29
0.47
1.1
1.1
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
23
288
0.80
0.47
2.4
2.6
—
—
—
0
0
(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum
23
287
0.80
0.46
1.1
1.1
u/ml
3.9
0.5
0.43
16
202
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
28
341
0.82
0.45
1.4
1.4
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
79
702
1.12
0.45
1.7
1.7
%
105.2
100.5
0.55
66
629
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
282
2653
1.06
0.44
1.3
1.3
u/ml
1.1
3.6
1.40
24
206
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
113
1238
0.91
0.44
1.2
1.4
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
62
543
1.14
0.44
1.2
1.1
iu/ml
144.7
158.0
0.28
62
538
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
21
263
0.80
0.44
1.1
1.1
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
35
415
0.84
0.43
1.1
1.1
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
45
522
0.86
0.43
1.5
1.6
—
—
—
0
0
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
16
121
1.32
0.43
1.0
1.4
%
67.5
60.5
0.27
11
107
(36660697) Celiac disease serology panel - Serum
1026
10533
0.97
0.43
1.2
1.2
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
292
2754
1.06
0.43
2.5
2.1
mg/l
10.6
10.2
0.39
282
2581
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
9
129
0.70
0.43
1.0
1.2
—
—
—
0
0
(3024471) HLA-A [Type]
29
238
1.22
0.43
1.0
1.0
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
14
104
1.34
0.42
1.1
1.1
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
323
3059
1.05
0.42
7.3
8.7
mmol/l
24.1
24.2
0.36
292
2894
(21494815) CD4 cells/100 lymphocytes in Specimen
76
847
0.89
0.42
2.1
2.1
%
49.6
44.8
0.74
11
147
(3042631) Mycobacterium sp identified in Specimen
83
744
1.11
0.41
1.9
2.7
—
—
—
0
0
(3024932) HLA-DR beta [Type]
28
230
1.22
0.41
1.1
1.2
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
5
33
1.51
0.41
1.0
1.1
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
773
7470
1.03
0.41
1.4
1.6
mu/l
309.3
318.8
0.09
679
6642
(3002621) Streptococcal DNAse B [Units/volume] in Serum
8
59
1.35
0.40
1.1
1.1
—
—
—
0
0
(3007919) Fasciola sp Ab [Titer] in Serum
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(40769427) Triglyceride [Moles/volume] in Peritoneal fluid
0
17
0.00
0.40
0.0
1.4
—
2080.6
—
0
17
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
169
1570
1.08
0.40
1.2
1.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
169
1570
1.08
0.40
1.2
1.2
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
218
2044
1.07
0.40
1.3
1.2
u/ml
3.6
3.8
0.16
87
859
(3018851) Theophylline [Moles/volume] in Serum or Plasma
8
60
1.33
0.40
3.0
2.1
umol/l
59.5
42.3
—
8
60
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
58
510
1.14
0.40
1.2
1.1
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
195
1822
1.07
0.40
1.2
1.3
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
24
195
1.23
0.39
1.2
1.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
1061
10866
0.97
0.39
1.3
1.3
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
8
61
1.31
0.39
1.0
1.0
—
—
—
0
0
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
26
313
0.83
0.39
2.9
2.8
ng/l
164.5
86.2
0.56
13
147
(3033086) Enterovirus NOS Ab [Titer] in Serum
5
35
1.43
0.39
1.0
1.1
—
—
—
0
0
(3020934) Sesame Seed IgE Ab [Units/volume] in Serum
0
19
0.00
0.39
0.0
1.0
—
0.2
—
0
9
(3019977) pH of Arterial blood
37
315
1.17
0.39
1.7
2.8
ph
7.4
7.4
1.02
11
84
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
319
3029
1.05
0.39
1.2
1.3
u/ml
37.1
40.3
0.14
41
323
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
10
71
1.41
0.38
1.8
2.0
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
143
1323
1.08
0.38
1.1
1.1
—
62.6
—
0
11
(3004616) Nuclear Ab [Presence] in Serum
139
1496
0.93
0.38
1.3
1.4
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
43
494
0.87
0.38
1.3
1.4
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
219
2059
1.06
0.38
1.2
1.2
—
—
—
0
0
(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum
28
233
1.20
0.37
1.2
1.1
u/ml
0.0
0.0
0.88
14
148
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
545
5244
1.04
0.37
1.1
1.1
u/ml
1.0
5.0
—
8
74
(3034426) Prothrombin time (PT)
36
418
0.86
0.37
1.4
1.2
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
359
3425
1.05
0.37
1.3
1.3
u/ml
6.1
8.6
0.40
55
569
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
212
1995
1.06
0.36
1.1
1.1
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
32
271
1.18
0.36
2.3
1.9
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
200
1879
1.06
0.36
1.2
1.2
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
1338
13067
1.02
0.36
2.6
2.4
e6/l
5.8
4.9
1.25
685
6567
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
67
600
1.11
0.36
2.3
2.6
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
186
1744
1.07
0.36
1.5
1.5
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
28
331
0.84
0.36
1.4
1.4
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
6
41
1.46
0.36
3.5
3.3
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
6
41
1.46
0.36
1.3
1.3
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
112
1030
1.09
0.36
2.3
2.4
e9/l
1.2
1.3
0.35
72
589
(3000012) Reticulocyte production index
40
346
1.15
0.35
1.2
1.4
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
1694
16592
1.02
0.35
1.8
1.8
—
—
—
0
0
(44806071)
23
189
1.21
0.35
1.2
1.1
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
1887
18507
1.02
0.35
1.5
1.5
nmol/l
21.1
21.2
0.01
1703
16273
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
9
123
0.73
0.35
1.6
1.8
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
111
1022
1.08
0.35
1.3
1.4
mmol/l
71.6
64.8
0.77
82
795
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
24
287
0.83
0.35
1.8
2.1
ug/l
2.3
5.1
0.74
16
172
(3052851) Hemolysis interference index of Serum or Plasma
271
2573
1.05
0.35
2.7
2.6
—
—
—
0
0
(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum
13
167
0.78
0.34
1.1
1.0
u/ml
0.2
0.2
—
7
87
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
17
135
1.26
0.34
1.0
1.0
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
83
907
0.91
0.34
1.3
1.4
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
123
1140
1.08
0.33
1.1
1.1
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
110
1015
1.08
0.33
2.0
1.7
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
98
1061
0.92
0.33
1.3
1.2
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
20
242
0.82
0.33
1.1
1.1
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
50
443
1.13
0.33
1.3
1.7
—
—
—
0
0
(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum
16
127
1.26
0.33
1.8
1.6
mg/l
1.4
1.9
—
8
86
(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum
16
127
1.26
0.33
1.8
1.6
mg/l
2.6
2.5
—
9
81
(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum
16
127
1.26
0.33
1.8
1.6
mg/l
2.9
4.3
—
10
77
(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum
16
127
1.26
0.33
1.8
1.6
mg/l
0.2
1.2
—
8
71
(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum
16
127
1.26
0.33
1.8
1.6
mg/l
0.6
1.9
—
10
88
(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum
16
127
1.26
0.33
1.8
1.6
mg/l
1.0
2.0
—
8
70
(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum
16
127
1.26
0.33
1.8
1.6
mg/l
0.7
2.7
—
10
83
(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum
16
127
1.26
0.33
1.8
1.6
mg/l
1.2
0.9
—
7
80
(3003633) Ovomucoid IgE Ab [Units/volume] in Serum
6
88
0.68
0.33
1.0
1.1
u/ml
0.2
6.1
—
6
71
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
7454
74786
0.99
0.32
2.9
2.7
u/l
36.7
34.0
3.09
7127
71322
(3048879) Bone marrow aspiration report
10
132
0.76
0.32
1.7
2.5
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
31
359
0.86
0.32
1.4
1.4
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
4475
45052
0.99
0.32
2.5
2.3
nmol/l
74.6
2031.3
0.50
4227
41934
(3014891) Appearance of Pleural fluid
6
47
1.27
0.32
1.5
2.0
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
40
454
0.88
0.32
1.6
1.7
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
17
208
0.82
0.31
3.3
2.3
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
100
1078
0.92
0.31
1.3
1.2
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
14
175
0.80
0.31
1.7
2.2
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
319
3053
1.04
0.31
1.1
1.1
—
—
—
0
0
(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum
13
164
0.79
0.31
1.1
1.0
u/ml
0.0
0.0
—
7
88
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
26
304
0.85
0.31
1.5
1.9
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
100
1075
0.93
0.30
1.3
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
100
1075
0.93
0.30
1.3
1.2
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
78
714
1.09
0.29
1.1
1.2
—
—
—
0
0
(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid
10
75
1.33
0.29
1.1
1.6
%
32.4
32.7
—
5
53
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
99
1064
0.93
0.29
1.3
1.2
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
104
965
1.08
0.29
1.3
1.2
u/ml
0.2
0.9
1.58
46
367
(42529406) Shigella sp [Presence] in Stool by Culture
335
3473
0.96
0.29
1.2
1.2
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
266
2542
1.05
0.28
1.4
1.3
ug/g
312.7
305.9
0.20
158
1309
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
99
1062
0.93
0.28
1.3
1.2
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
168
1587
1.06
0.28
2.9
3.5
u/ml
0.4
0.4
0.52
96
888
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
26
301
0.86
0.28
1.4
1.9
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
26
301
0.86
0.28
1.4
1.9
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
37
417
0.88
0.28
1.0
1.1
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
8
63
1.27
0.27
1.0
1.0
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
11
85
1.29
0.27
1.5
1.3
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
97
1039
0.93
0.27
1.1
1.1
—
—
—
0
0
(40768441) Liver Pathology biopsy report
80
737
1.08
0.27
1.5
1.3
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
8
64
1.25
0.27
1.3
1.1
—
—
—
0
0
(3010375) cycloSPORINE [Mass/volume] in Blood
38
336
1.13
0.27
24.2
26.9
ug/l
110.5
113.5
0.12
33
274
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
89
824
1.08
0.27
1.3
1.6
—
—
—
0
0
(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid
8
65
1.23
0.27
1.0
1.1
u/l
—
4.2
—
0
15
(4010399)
644
6590
0.97
0.26
1.4
1.4
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
874
8908
0.98
0.26
2.5
2.3
u/l
34.1
36.2
0.37
725
7626
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
331
3423
0.96
0.26
1.2
1.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
246
2354
1.04
0.26
1.1
1.2
—
—
—
0
0
(3018133) Calcium [Moles/volume] in Urine
12
149
0.80
0.26
1.2
1.8
mmol/l
3.4
2.9
0.27
12
135
(3000285) Sodium [Moles/volume] in Blood
9
72
1.25
0.25
1.0
1.1
—
—
—
0
0
(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum
16
132
1.21
0.25
1.8
1.6
mg/l
0.7
2.5
—
10
82
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
30
263
1.14
0.25
1.0
1.1
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
30
263
1.14
0.25
1.0
1.1
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
30
263
1.14
0.25
1.0
1.1
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
215
2239
0.96
0.24
1.2
1.1
au/ml
10.9
11.2
0.02
15
170
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
65
597
1.09
0.24
1.5
1.6
u/l
10.6
4.8
0.81
35
277
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
11
137
0.80
0.24
1.0
1.2
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
240
2302
1.04
0.24
2.5
2.0
g/l
3.7
3.6
0.90
177
1674
(3023410) Appearance of Cerebral spinal fluid
126
1189
1.06
0.23
1.3
1.4
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
145
1374
1.05
0.23
1.1
1.1
%
96.1
93.9
0.52
135
1291
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
34
302
1.12
0.23
2.1
2.1
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
107
1005
1.06
0.23
1.0
1.0
u/ml
0.7
2.5
1.04
27
219
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
223
2137
1.04
0.23
2.5
2.0
g/l
10.4
10.1
0.31
196
1807
(3014765) Yersinia sp identified in Stool by Organism specific culture
336
3462
0.97
0.23
1.2
1.1
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
74
794
0.93
0.23
1.3
1.7
mosm/kgh2o
280.9
280.6
0.05
58
628
(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis
5
38
1.31
0.23
1.4
1.1
u/l
380.8
274.3
—
5
33
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
64
690
0.93
0.23
1.1
1.1
u/ml
3.2
11.0
3.85
11
122
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
240
2306
1.04
0.22
2.5
2.0
g/l
7.3
7.2
0.09
186
1775
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
48
437
1.10
0.22
1.0
1.2
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
189
1807
1.04
0.22
2.3
2.6
—
—
—
0
0
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
117
1105
1.06
0.22
1.3
1.3
umol/l
5.3
5.4
0.17
112
1019
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
88
935
0.94
0.22
1.5
1.2
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
207
2148
0.96
0.21
1.2
1.4
—
—
—
0
0
(4015189)
13
156
0.83
0.21
1.9
2.3
—
—
—
0
0
(3002814) Trichinella spiralis Ab [Titer] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(36303858) Crystals [Presence] in Urine
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3015350) Toxocara sp Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3044316) Mercury [Moles/volume] in Urine
0
11
0.00
0.21
0.0
1.2
—
7.1
—
0
5
(3035153) Lemon IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
12
145
0.83
0.21
1.3
1.3
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
1009
10233
0.98
0.21
1.7
1.7
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
4847
48650
0.99
0.21
5.6
5.9
%
7.8
7.9
3.92
4588
45903
(3028679) Herpes simplex virus Ab [Presence] in Serum
93
874
1.06
0.21
1.2
1.2
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
245
2531
0.97
0.21
1.1
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
245
2530
0.97
0.20
1.1
1.1
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
239
2303
1.04
0.20
2.5
2.0
—
—
—
0
0
(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid
0
14
0.00
0.20
0.0
1.0
—
10817.2
—
0
6
(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum
14
117
1.19
0.20
1.1
1.0
u/ml
1.7
0.1
—
7
72
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
57
527
1.08
0.20
1.0
1.0
—
—
—
0
0
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
6
49
1.22
0.20
1.0
1.0
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
14
165
0.85
0.19
2.1
2.6
—
—
—
0
0
(3034459) Mononuclear cells/100 leukocytes in Pleural fluid
6
50
1.20
0.19
1.5
1.3
%
71.5
69.7
—
6
43
(3017354) Segmented neutrophils/100 leukocytes in Blood
63
674
0.93
0.19
2.0
2.7
%
58.6
55.6
0.46
36
425
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
46
422
1.09
0.19
1.3
1.3
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
81
761
1.06
0.19
1.1
1.1
nmol/l
417.0
407.2
0.18
75
709
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
56
601
0.93
0.19
1.2
1.3
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
11
90
1.22
0.19
1.1
1.0
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
29
321
0.90
0.18
1.3
1.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
29
321
0.90
0.18
1.3
1.4
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
27
300
0.90
0.18
1.1
1.1
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
32
289
1.11
0.18
3.3
2.9
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
23
258
0.89
0.18
1.1
1.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
101
958
1.05
0.18
1.2
1.2
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
216
2085
1.03
0.18
1.1
1.1
—
—
—
0
0
(3011325) HIV 1+2 Ab [Presence] in Serum
7
60
1.16
0.17
1.0
1.1
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
7
60
1.16
0.17
1.0
1.1
—
—
—
0
0
(3035880) pH of Pleural fluid
18
205
0.88
0.17
1.2
1.2
—
—
—
0
0
(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection
11
91
1.21
0.17
1.2
1.3
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
313
3043
1.03
0.17
2.0
1.9
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
2209
22229
0.99
0.17
2.0
2.0
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
36
391
0.92
0.16
1.4
1.4
e6/l
4159.8
41167.2
2.04
14
220
(3023430) Cat dander IgE Ab [Units/volume] in Serum
228
2344
0.97
0.16
1.1
1.1
u/ml
3.8
4.8
0.50
83
960
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
90
944
0.95
0.16
1.2
1.2
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
489
4784
1.02
0.16
1.7
1.7
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
112
1069
1.05
0.16
2.1
2.0
u/ml
75.9
1357.7
0.70
100
933
(3020874) Milk IgE Ab [Units/volume] in Serum
108
1030
1.05
0.16
1.1
1.0
u/ml
0.4
1.2
1.25
26
270
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
8
70
1.14
0.16
2.3
3.0
—
—
—
0
0
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
53
565
0.94
0.16
1.1
1.2
u/l
59.1
84.3
4.48
48
498
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
82
777
1.05
0.16
1.5
1.6
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
554
5627
0.98
0.16
1.8
1.6
mg/l
4.8
3.2
0.85
395
3824
(3010370) Gastrin [Moles/volume] in Serum or Plasma
18
158
1.14
0.15
1.2
1.9
pmol/l
36.4
53.7
0.62
12
138
(3027974) Hepatitis B virus e Ag [Presence] in Serum
6
76
0.79
0.15
1.0
1.5
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
4660
46717
0.99
0.15
5.4
5.8
%
0.7
0.7
2.98
4374
43717
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
23
255
0.90
0.15
1.3
1.3
nmol/l
117.9
111.9
0.07
16
197
(3007463) Buprenorphine [Presence] in Urine
6
80
0.75
0.15
11.8
8.3
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
278
2845
0.97
0.15
1.1
1.1
u/ml
1.5
1.9
0.52
63
692
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
229
2222
1.03
0.15
1.6
1.5
iu/ml
8.7
15.0
—
10
58
(3006504) Eosinophils/100 leukocytes in Blood
4829
48398
0.99
0.15
5.4
5.7
%
2.8
2.8
1.04
4531
45291
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
207
2006
1.03
0.15
2.3
2.1
ug/l
239.5
447.8
1.00
187
1771
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
30
274
1.09
0.14
1.1
1.1
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
846
8331
1.01
0.14
2.3
2.3
au/ml
19.4
22.3
0.41
56
653
(3045683) HLA typing for celiac disease panel - Blood or Tissue
106
1015
1.04
0.14
1.0
1.0
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
90
939
0.96
0.14
1.2
1.2
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
17
191
0.89
0.14
2.2
2.9
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
35
377
0.93
0.14
1.1
1.1
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
52
551
0.94
0.14
1.1
1.2
u/l
11.6
19.6
2.59
46
472
(3045142) Bone marrow Pathology biopsy report
70
664
1.05
0.13
1.2
1.3
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
20
179
1.12
0.13
1.2
1.8
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
231
2364
0.97
0.13
1.1
1.1
u/ml
2.6
2.8
0.07
132
1280
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
38
407
0.93
0.13
1.3
1.3
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
83
792
1.05
0.13
2.2
2.5
e6/l
540.5
514.0
0.31
68
651
(3011897) Casein IgE Ab [Units/volume] in Serum
26
283
0.92
0.13
1.2
1.1
u/ml
0.0
2.7
—
6
54
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
160
1645
0.97
0.13
2.3
2.0
g/l
0.0
0.0
0.00
154
1504
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
9
106
0.85
0.13
1.1
1.1
—
—
—
0
0
(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum
9
106
0.85
0.13
1.0
1.1
u/ml
0.0
0.5
—
9
96
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
24
262
0.91
0.13
2.1
2.5
—
—
—
0
0
(3019174) dRVVT (LA screen)
15
132
1.13
0.12
1.5
1.2
—
—
—
0
0
(4268621)
145
1402
1.03
0.12
2.3
2.3
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
39
416
0.94
0.12
1.3
1.3
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
162
1664
0.97
0.12
2.3
2.0
g/l
0.0
0.0
0.50
155
1507
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
115
1188
0.97
0.12
1.5
1.5
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
21
190
1.10
0.12
1.0
1.1
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
76
726
1.04
0.12
1.3
1.6
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
47
443
1.06
0.11
1.4
1.4
e6/l
2003.9
2565.3
0.52
32
322
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
84
872
0.96
0.11
1.2
1.3
mmol/l
2.0
1.9
0.23
77
821
(3012441) Differential panel - Pleural fluid
34
363
0.93
0.11
1.3
1.4
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
1643
16511
0.99
0.11
2.5
2.3
ug/g
110.9
100.4
0.62
1301
12857
(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum
18
198
0.91
0.11
1.1
1.0
u/ml
0.4
0.1
—
10
114
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
10
115
0.87
0.11
1.1
1.1
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
1253
12604
0.99
0.11
1.3
1.3
iu/l
25.9
26.7
0.41
1122
10998
(3014148) Varicella zoster virus Ab [Titer] in Serum
202
2061
0.98
0.10
1.2
1.2
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
28
300
0.93
0.10
3.0
2.8
—
—
—
0
0
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
14
156
0.90
0.10
2.6
4.8
u/l
38.2
43.0
—
9
56
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
129
1251
1.03
0.10
5.0
3.9
u/ml
52.7
38.1
0.41
129
1246
(40765096) Chromosome analysis panel by Banding
18
163
1.10
0.10
1.0
1.1
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
40
377
1.06
0.10
1.3
1.5
u/l
11.9
11.1
0.34
40
365
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
81
779
1.04
0.10
2.1
2.5
e9/l
0.2
0.2
0.35
68
655
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
12
135
0.89
0.10
1.0
1.1
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
5
44
1.13
0.10
1.0
1.1
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
178
1816
0.98
0.09
2.2
1.9
g/l
38.2
38.9
0.90
166
1582
(3014133) Dog dander IgE Ab [Units/volume] in Serum
243
2470
0.98
0.09
1.1
1.1
u/ml
2.4
4.7
2.30
86
923
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
17
186
0.91
0.09
1.2
1.1
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
32
300
1.06
0.09
1.5
1.7
ug/l
8.0
8.6
0.44
32
300
(3035933) Granulocytes/100 leukocytes in Blood
36
380
0.95
0.09
1.5
1.6
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
51
486
1.05
0.09
1.1
1.2
u/l
13.3
18.9
0.89
37
384
(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid
5
48
1.04
0.09
1.4
1.1
u/l
22.8
30.4
—
5
33
(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method
22
237
0.93
0.09
1.1
1.2
nmol/l
0.4
0.4
0.01
15
160
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
66
684
0.96
0.09
2.2
2.7
e6/l
1013.2
842.5
1.34
25
321
(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma
6
54
1.11
0.09
1.0
1.1
u/l
34.0
46.6
—
6
43
(3027570) Oxalate [Moles/time] in 24 hour Urine
6
55
1.09
0.08
2.2
1.4
umol/24h
316.5
307.1
—
6
55
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
36
340
1.06
0.08
1.1
1.0
ng/l
312.0
345.8
0.34
28
254
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
104
1009
1.03
0.08
1.1
1.2
u/l
60.4
57.9
0.19
75
674
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
43
450
0.95
0.08
1.4
1.4
u/ml
20.4
18.7
—
5
90
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
17
185
0.92
0.08
1.6
2.1
e6/l
481.8
22472.2
1.05
11
87
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
37
389
0.95
0.08
1.1
1.1
—
—
—
0
0
(3010015) Selenium [Moles/volume] in Serum or Plasma
14
126
1.11
0.08
2.9
1.8
umol/l
1.3
1.3
0.09
14
112
(3025315) Body weight
5
61
0.82
0.08
3.6
3.7
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
40
380
1.05
0.08
2.2
2.0
—
—
—
0
0
(3011841) English Walnut IgE Ab [Units/volume] in Serum
15
164
0.91
0.08
1.1
1.0
u/ml
0.2
0.8
—
10
120
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
36
341
1.05
0.08
1.1
1.0
ng/l
773.1
772.0
0.00
28
248
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
7
66
1.06
0.08
1.3
1.1
u/l
7.0
12.6
—
7
66
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
43
410
1.05
0.08
1.1
1.2
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
7
68
1.03
0.07
1.0
1.2
—
—
—
0
0
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
51
489
1.04
0.07
1.1
1.2
u/l
71.4
76.3
0.40
39
398
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
87
844
1.03
0.07
1.2
1.3
u/ml
13.7
4.0
—
8
72
(4146454)
59
568
1.04
0.07
3.1
2.8
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
11
98
1.12
0.07
1.7
1.8
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
53
549
0.96
0.07
1.2
1.1
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
37
387
0.95
0.07
1.1
1.1
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
294
2972
0.99
0.07
1.1
1.1
u/ml
2.6
4.9
5.06
131
1524
(3044927) Protein electrophoresis panel - Urine
48
498
0.96
0.07
1.1
1.2
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
139
1415
0.98
0.07
1.4
1.6
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
39
372
1.05
0.07
1.1
1.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
748
7519
0.99
0.07
1.4
1.5
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
12
132
0.91
0.07
1.0
1.1
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
201
1974
1.02
0.07
2.3
2.1
g/l
0.7
0.5
0.19
185
1735
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
30
284
1.05
0.07
1.1
1.1
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
36
343
1.05
0.06
1.1
1.0
ng/l
36.8
42.6
0.48
27
249
(3020393) Adenovirus Ag [Presence] in Stool
8
92
0.87
0.06
1.1
1.0
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
37
353
1.05
0.06
1.0
1.0
mg/g
4.9
5.2
0.35
37
329
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
776
7689
1.01
0.06
1.3
1.3
au/ml
29.9
41.1
0.95
37
296
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
241
2372
1.01
0.06
2.7
3.0
mmol/l
24.7
24.7
0.16
225
2220
(3017446) Testosterone [Moles/volume] in Serum or Plasma
174
1765
0.98
0.06
1.3
1.3
nmol/l
1.3
1.4
0.77
144
1458
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
423
4260
0.99
0.06
2.3
2.3
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
90
877
1.02
0.06
1.2
1.3
u/ml
45.6
45.0
—
9
78
(3052592) Norovirus Ag [Presence] in Stool
15
138
1.08
0.06
1.0
1.2
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
69
670
1.03
0.06
1.1
1.1
miu/ml
1475.3
1471.6
0.01
69
670
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
83
848
0.98
0.05
1.1
1.1
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
34
354
0.96
0.05
1.5
1.4
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
40
384
1.04
0.05
1.3
1.8
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
40
384
1.04
0.05
1.3
1.8
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
40
384
1.04
0.05
1.3
1.8
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
40
384
1.04
0.05
1.3
1.8
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
18
168
1.07
0.05
1.1
1.1
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
1362
13647
1.00
0.05
1.2
1.2
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
51
525
0.97
0.05
1.3
1.2
—
—
—
0
0
(3018001) Oat IgE Ab [Units/volume] in Serum
11
120
0.91
0.05
1.0
1.1
u/ml
1.1
1.5
—
5
46
(3023183) Ammonium ion [Moles/volume] in Plasma
126
1278
0.98
0.05
4.2
2.9
umol/l
34.7
32.4
0.58
112
1108
(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum
16
149
1.07
0.05
1.1
1.0
u/ml
0.5
0.4
—
9
80
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
47
483
0.97
0.04
1.6
2.1
ug/l
18.2
20.5
0.36
47
474
(40768806) Pleura Pathology biopsy report
39
402
0.97
0.04
1.3
1.4
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
20
189
1.06
0.04
1.0
1.2
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
41
422
0.97
0.04
1.1
1.3
—
637.5
—
0
12
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
115
1165
0.98
0.04
1.3
1.6
—
—
—
0
0
(40758558) Short blood count panel - Blood
2534
25339
1.00
0.04
5.7
6.4
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
327
3288
0.99
0.04
1.2
1.1
u/ml
2.2
1.3
0.62
114
1254
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
39
377
1.03
0.04
1.5
1.6
au/ml
83.2
147.7
—
5
50
(3008401) Mugwort IgE Ab [Units/volume] in Serum
283
2801
1.01
0.04
1.1
1.1
u/ml
0.7
1.0
1.07
104
1143
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
1285
12781
1.00
0.04
1.6
1.7
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
11
101
1.09
0.04
1.0
1.0
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
50
511
0.98
0.03
1.0
1.0
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
93
914
1.02
0.03
1.2
1.5
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
99
974
1.01
0.03
1.7
1.6
%
50.0
49.1
0.08
67
590
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
184
1820
1.01
0.03
2.2
2.0
g/l
0.0
0.0
1.70
176
1656
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
10
92
1.08
0.03
1.1
1.1
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
37
379
0.97
0.02
1.2
1.1
ng/l
62.6
500.4
—
8
72
(3030313) Adrenal Ab [Titer] in Serum
20
191
1.04
0.02
1.1
1.0
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
40
409
0.98
0.02
1.2
1.3
titre
75.7
48.5
—
7
39
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
76
747
1.02
0.02
1.2
1.3
g/l
1.4
1.5
—
5
40
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
31
318
0.97
0.02
1.1
1.1
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
224
2222
1.01
0.02
2.5
2.0
g/l
3.0
3.0
0.19
182
1738
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
77
778
0.99
0.02
1.2
1.2
titre
246.0
169.8
0.29
15
141
(4024509)
82
828
0.99
0.02
1.5
1.5
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
202
2004
1.01
0.01
1.1
1.0
u/ml
0.2
0.3
0.55
36
393
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
25
242
1.03
0.01
3.3
4.6
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
86
849
1.01
0.01
1.2
1.2
—
—
—
0
0
(40768443) Skin Pathology biopsy report
426
4262
1.00
0.01
1.2
1.2
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
13
136
0.95
0.01
1.6
1.2
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
789
7862
1.00
0.01
2.0
2.4
e9/l
4.5
4.1
2.22
672
6540
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
10
94
1.06
0.00
1.9
2.3
—
—
—
0
0
(3036312) Salmon IgE Ab [Units/volume] in Serum
10
94
1.06
0.00
1.1
1.1
u/ml
0.2
0.6
—
10
60
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
11
106
1.04
0.00
2.3
2.1
u/field
1.0
0.9
0.14
11
106
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
20
202
0.99
0.00
1.4
3.1
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
20
202
0.99
0.00
1.4
3.1
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
12
119
1.01
0.00
2.1
2.1
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
19
188
1.01
0.00
1.8
1.5
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
14
144
0.97
0.00
1.4
1.5
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
126
1257
1.00
0.00
2.5
3.4
u/ml
266.3
474.0
0.33
117
1137
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
95
945
1.00
0.00
1.1
1.1
iu/ml
8.8
8.3
0.09
30
272
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
26
256
1.01
0.00
1.1
1.1
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
53
525
1.01
0.00
1.1
1.0
u/ml
6.4
8.6
—
5
81
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
13
128
1.01
0.00
2.5
2.0
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
36
354
1.01
0.00
1.0
1.1
—
—
—
0
0
(21494434) Karyotype in Bone marrow
46
462
0.99
0.00
1.2
1.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
57
570
1.00
0.00
1.2
1.1
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
10
103
0.97
0.00
1.3
1.6
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
24
234
1.02
0.00
1.3
1.4
—
—
—
0
0
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
47
473
0.99
0.00
1.8
1.8
mg/l
8.0
9.5
0.93
39
379
(3007164) IgA [Mass/volume] in Serum or Plasma
2487
24815
1.00
0.00
1.4
1.4
g/l
2.2
2.1
1.07
1645
15637
(3027231) Wheat IgE Ab [Units/volume] in Serum
30
303
0.99
0.00
1.1
1.0
—
1.1
—
0
6
(3023420) DNA double strand Ab [Units/volume] in Serum
147
1472
1.00
0.00
1.9
1.6
iu/ml
37.8
32.9
0.22
13
75
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
26
254
1.02
0.00
1.0
1.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
758
7560
1.00
0.00
1.5
1.5
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
646
6449
1.00
0.00
1.3
1.3
miu/ml
195.4
231.9
2.17
324
3276
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
37
369
1.00
0.00
1.0
1.1
—
—
—
0
0
(3000492) Spirometry study
1043
10402
1.00
0.00
1.3
1.4
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
105
1044
1.00
0.00
1.2
1.1
—
45.4
—
0
13
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
18
184
0.98
0.00
1.1
1.4
—
—
—
0
0
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
6
66
0.91
0.00
1.2
1.0
—
—
—
0
0
(3007147) Virus identified in Stool by Electron microscopy
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(4038314)
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013945) Hepatitis B virus e Ab [Presence] in Serum
7
74
0.94
0.00
1.0
1.5
—
—
—
0
0
(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine
0
8
0.00
0.00
0.0
1.0
—
22.8
—
0
8
(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
6
64
0.94
0.00
1.7
1.4
—
—
—
0
0
(3028468) Fragments [Presence] in Blood by Light microscopy
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020123) Porphyrins [Interpretation] in Serum or Plasma
7
78
0.90
0.00
1.0
1.1
—
—
—
0
0
(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
8
87
0.92
0.00
1.0
1.6
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
5
50
1.00
0.00
1.2
1.2
—
—
—
0
0
(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3000219) Insulin receptor Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
9
90
1.00
0.00
1.6
1.5
pmol/l
3.2
16.0
—
9
76
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
5
54
0.92
0.00
1.0
1.4
—
—
—
0
0
(43055189) Lymphocytes [#/area] in Urine sediment by Microscopy high power field
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027401) Testosterone Free/Testosterone.total in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
1.1
—
0
6
(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline
0
7
0.00
0.00
0.0
1.0
—
299.4
—
0
7
(3027035) Albumin [Mass/time] in 24 hour Urine
8
82
0.97
0.00
1.5
1.3
—
137.6
—
0
10
(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006498) Trichoderma viride IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint O15_GESTAT_HYPERT and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| O15_GESTAT_HYPERT | 0.601 [0.52, 0.7] | < 0.001 |
| Birth year | 0.996 [0.99, 1.0] | 0.39 |
During the follow-up period (1.1.1998 — 31.12.2019), 332 out of 52846 females with O15_GESTAT_HYPERT died.
Males
No dataMortality risk
Mortality risk for people of age
years, who have O15_GESTAT_HYPERT.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.07% | No data |
| 5 | 0.382% | No data |
| 10 | 0.969% | No data |
| 15 | 1.82% | No data |
| 20 | 3.187% | No data |
Relationships between endpoints
↥Index endpoint: O15_GESTAT_HYPERT – Gestational [pregnancy-induced] hypertension
GWS hits: 20
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data